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The work described in this thesis was carried out in the 
School of Chemistry of the University of Bath between October 
1972 and September 1975.
Mass Spectra were recorded on an AEI MS12 mass spectro­
meter.
NMR Spectra were obtained with either a Varian A6Ü 
(60 MHz) or a Deol 100 MHz spectrometer.
IR Spectra were obtained with a Perkin Elmer PE237 
spectrophotometer.
UV Spectra were obtained with a Perkin Elmer PE402 
spectrophotometer.




The work described in this thesis was stimulated by the 
observations of several Indian workers who had endeavoured to 
show a link between the ingestion of products of the poppy 
Arqemone mexicana, Linn, and the development of a variety of 
debilitating diseases, notably the eye condition Glaucoma, 
although other complaints, mainly cardiac and circulatory were 
also noted. The role of sanguinarine as an environmental 
carcinogen was also suggested.
Chapter 1 of this thesis comprises a summary of the occur­
rence, biosynthesis, and in-vitro synthesis of benzo(c)phenan- 
thridine alkaloids in general and sanguinarine, 2,3,7,8- 
dimethylenedioxy-5-methyl-benzo(c)phenanthridine, in particular.
Chapter 2 attempts to summarise the pharmacological and 
toxicological properties of sanguinarine and of the papaver 
Arqemone mexicana, Linn, in the context of the aetiology of the 
eye disease glaucoma. A quantitative analytical technique for 
detecting sanguinarine in physiological quantities is described 
and examination of material from clinical cases of Argemone 
poisoning is reported.
Chapter 3 discusses the possible role of sanguinarine or a 
metabolite as an environmental carcinogen. The results of 
feeding experiments and of the examination of tissue samples
vu
are reported.
Chapter 4 describes some synthetic studies undertaken to 
explore routes to specifically radio-labelled sanguinarine 
derivatives for use in the investigation of the postulated 
in-vivo rearrangement of sanguinarine.
CHAPTER 1
OCCURRENCE
Up to the present time, twenty-three naturally occurring 
benzo(c)phenanthridine alkaloids have been characterised in the 
literature. Of these, twelve are derived from the unsaturated 
skeleton (1) and are shown in Table 1. A further group of ten 
are based on the unsaturated skeleton (2): These are shown in 
Table 2.
(1 )
Finally, one alkaloid, bocconoline (3) has been shown to be 
based on the 5,6-dihydrobenzo(c)phenanthridine skeleton (4).
CH2OH
(3)
Several artefacts have been isolated and these are shown in 
Table 5, It can be seen that the majority of these artefacts
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C=0 (40) bis-che(erythriny( acetone
CH
8
arise from disproportionation of the pseudobase (5), Thus,
H OH
sanguinarine (6) gives rise to dihydrosanguinarine (25) and 
oxysanguinarine (26), The disproportionation is thought to 
take place during the isolation procedure and that it is not an 
in-vivo process.
The majority of the work on this class of compounds has 
been carried out in the last twenty years although sanguinarine 
(6) was first isolated in 1829, Prior to 1959, five alkaloids 
had been isolated: sanguinarine (6), chelerythrine (7), 
chelidonine (20), homochelidonine (21) and methoxychelidonine 
(23),
Avicine (S) andndtidine (9) were identified by Arthur and
2Ng in 1959, The methoxylated derivatives chelirubine (15),
chelilutine (16), sanguirubine (13), sanguilutine (14) and
3
marcapine (19) were originally identified by Slavik and were
thought to be methoxylated in Ring B, More recent work by 
k
Ishii et al has characterised chelirubine as structure (17) and
shows its identity with bocconine, previously thought to be 
structure (18), This has cast doubt on the original character­
isations, and the structures and biogenesis of the other four 
alkaloids is now ambiguous.
Three nor-N-methyl compounds occur: norchelidonine (22)
5,7and norsanguinarine (10) were discovered by Slavik, while
norchelerythrlne (11) was discovered by Govindachari and 
8Viswanathan.
The two 13-methylbenzo(c)phenanthridines corynoline (25)
9,10and corynolOx.ine were both first characterised by Takao, whose 
11group also isolated the two epimers 14-epicorynoline (26) and 
11-epicorynoline (27). Two other 13-methyl derivatives have
been characterised: 12-B-hydroxycorynoline (28) by Nonaka and
12 , , 13 Nishioka and corynol§mine (29) by Ishii, Hosoya and Takao,
Bocconoline (24) was discovered by Ishii, Hosoya and
T UTakao,
Fagaronine (12) with a phenolic function in ring D was
15
first isolated by Messmer et al and subsequently synthesised by
16Stermitz and his group.
10
DISTRIBUTION
Benzo(c)ph8nanthridines, like other isoquinoline alkaloids,
17are found in the two botanical Orders RHOEDALES and RÜTALES, 
Within these orders, and again following the pattern of 
isoquinoline alkaloids in general, b8nzo(c)phenanthridina 
alkaloids are found in the Families PAPAUERACEAE and 
FUMARIACEAE of the Order Rhoedales and in the Family RUTACEAE 
of the Order Rutales. Much of the chemotaxonomic work has been 
carried out by the groups of Slavik and of Stermitz*
Originally, benzo(c)phenanthridine alkaloids were believed 
to be very rare, but it is now becoming apparent that members 
of this class of alkaloids, particularly sanguinarine (6), 
although present usually in trace quantities, are extremely
18widely distributed. Indeed, work by Hakim, Mijovic and Walker, 
who screened 53 species of papaveraceae and fumariaceae, showed 
sanguinarine (6) to be present in nearly every case. This led 
them to postulate the distributions of sanguinarine throughout 
a large proportion of all the 675 species of papaver and fumaria.
The most prolific source of benzo(c)phenanthridine
17
alkaloids are the papavers Sanquinaria canadensis and 
18Chelidonium majus. whilst the plant in which sanguinarine
11
17appears to be most abundant is Arqemone mexicana.
The results of an investigation into the chemotaxonomy of 
the genus Argemone carried out by Stermitz and his groupware 





















A. mexicana X X X X X X X
A. albiflora X X X X X
A. brevicornita X X
A. subfusiformis X X X X X
A. echimata X X
A. glauca X X X X X
A. pleiacantha X X X X
A. gracilata X X
A. polyanthemos X X X X
A. corymbosa X X X X
A. chlsosensis X X X
A. sanguinea X X X
A. aurantiacei X X
A. grandiflora X X X




The biosynthesis of isoquinoline alkaloids in general and 
benzo(c)phenanthridine alkaloids in particular is now well 
researched and fairly well understood. It is thought that the 
key bio-intermediate is a 1-benzylisoquinoline derived via 
norlaudanosoline (43), from dopamine (42a). Dopamine is 
thought to be formed by the decarboxylation of dihydroxy- 
phenylalanine (41), Dopamine condenses with the oc-ketoacid 












Experiments have shown that the necessary 1-benzylisoquin­
oline is (+)-reticuline (44), the partially 0-methylated 




Due to enzyme stereospecificity it is considered that only the 
(+) isomer is utilised in benzo(c)phenanthridine biosynthesis: 
indeed, benzo(c)phenanthridine biosynthesis is now seen as one 
of many biosynthetic routes which fall within the general 
scheme of isoquinoline biosynthesis from the common precursor 
norlaudanosoline. Thus, norlaudanosoline forms the (+)-and (-)-
23isomers of reticuline: the (-)-isomer is thought to be the 
precursor of the morphine group of alkaloids, whereas the (+)- 
isomer forms the tetrahydroprotoberberines and thus the 
protoberberines, phthalide isoquinolines and benzo(c)phenan- 
thridines. Another route from norlaudanosoline leads to
15
orientaline, the precursor of the proaporphines and aporphines.
Benzo(c)phenanthridine biosynthesis has been studied by 
Battersby, by Leete, by Stermitz and by others and in fairly 
recent work made possible by the increased sensitivity of 
modern radio-labelling techniques.
The bulk of the work has concentrated on chelidonine (20) 
but has been applied inter alia to sanguinarine.
25In an experiment by Leete,(-)-tyrosine-2- C (45) was fed 
to Chelidonium ma.lus and chelidonine-11-^^C-14-^^C (46) was 
isolated, as was similarly labelled sanguinarine (47). 
Degradative experiments showed the active chelidonine to be 
unequally labelled, with 61% of the activity at C-11, indi­
cating the possibility that tyrosine (or more probably its 
hydroxylated derivative) is converted in-vivo to two 
metabolites which subsequently condense.
26
A further experiment in which labelled dopamine (48) was 
fed to C. majus led to the isolation of chelidonine labelled at 
C-11 and also active (— ) stylopine-6— (49). This led to a 
final experimed^7in which the tetrahydroprotoberberine, (-)— 
styhopine-6-^^C was fed to C. ma.lus and chelidonine-11-^^C 
recovered, showing that the benzo(c)phenanthridine skeleton is 
formed by the rearrangement of a tetrahydroprotoberberine
16
intermediate (cf. references 28,29).
These experiments are summarised in Scheme No. 1.
Battersby^and Bartel fed (+)-reticuline-2-^^C (50) to 
C.ma.lus. Specifically labelled scoulerine (51) was isolated. 
Two reaction pathways were postulated, both involving a 
reaction of the N-oxide; that proposed by Barton proceeding via 
a rearrangement to the N-hydroxymethyl compound and subsequent 
condensation, whereas the more likely Battersby route involves 




the specificity of the label was proved by degradation.
14Using reticuline-2- C condensation can take place ortho- 
to the 1-benzyl hydroxy group to form scoulerine (39) as 
























as reported by Manske for Dicentra eximia.
Scoulerine, thus formed can undergo several oxidative pro­
cesses. These were investigated by Battersby et al. who fed 





the chelidonine extracted from the plant was found to be




This experiment reinforced the *berberine bridge* theory 
and indicated that methylenedioxy groupa are formed in-vivo 
from the o-mathoxyphenol system (this has since been achievec?^ 
in-vitro), but more importantly the absence of H at the 
benzo(c)phenanthridine C-14 position (and thus its initial 
complete loss from protoberberina C—14 position) indicated the 
formation of a 1|2-dihydroisoquinoline intermediate.
In order to investigate this further the totrahydro-
34 3protoberberine scoulerine was prepared with H labels at C-5, 
















The relative activities were shown to be (referring to 
scoulerine): 100^ loss of H from C—14, no loss from C-5, 50% 
loss from C—6, less than 50% from C—13# Battersby rationalised 
the above data by postulating the existence of the 1,2-dihydro- 
isoquinoline intermediate (56) shown below; the oxidation at 
C—6 is obviously stereospecific, as is the formation of the
21
C14—N double bond. The isomérisation to the 1,2-dihydroisoquin- 
oline is non-specific, leading to the observed isotope effect.




It is thought that the fully aromatic benzo(c)phenanthrid- 
iniura salts are derived from the corresponding chelidonine type 
of compound by a process involving dehydration and oxidation. 
Thus sanguinarine(6) and chelerythrine(7) are derived from 
scoulerine(51) via chelidonine(20)and homochelidonine(21). 
Similarly avicine(B) and nltidine(9) are derived from 
coreximine(52).
It is tempting to accept this; certainly, sanguinarine and 
chelerythrine often occur together with chelidonine and homo- 
chelidonine and the conversion of, for example, chelidonine 
into sanguinarine is a simple process in-vitro. It should be 
pointed out, however, that there is no confirmatory evidence 
and that the 11-hydroxy compounds (57a) and (57b),
HO R,
(57o) —0—CH2 — 0~
(57 b) -OCH] -OCH]
(57)
which would lead to auicine (57a) and nitidine (57b) have yet to
22
be found in Nature. It is possible then that sanguinarine is 
produced by a separate (although parallel) route to that which 
produces chelidonine.
IL
DERIVATIVES WITH MORE THAN FOUR OXYGEN FUNCTIONS
Initially these natural products were thought to be 
11-methoxy compounds and it was possible to propose a very 
simple biosynthesis which involved méthylation by a physiolog­
ical methylating agent, such as methionine* This intermediate 
would then proceed to the fully unsaturated benzo(c)phenan- 
thridine by the same route as that proposed for sanguinarine 
(qs).
URecent work by Ishii has, however, cast some doubt on the 
structure of this sub group of compounds and it would appear 
that the hydroxyl group at C-11 is not methylated but lost in 
the same way as for sanguinarine etc. The third oxygen 
function in Ring A may be inserted relatively late in the 
biosynthesis or it may be present in the biological "Starting 
materials". From a re-rationalisation of the existing 
biogenetic studies on macarpine (19) the former is more likely. 
Although the structure was originally thought të be (19) the 
work still stands for structure (58), the most likely one in 





Macarpine is believed to be derived from berberastine (59)
CH
Subjecting this tetrahydroprotoberberine to the 







In the original theory, méthylation followed by oxidation/ 
aromatisation led to macarpine; it would seem more likely that 
oxidation takes place first, producing the intermediate (61)
(58)
Hydroxylationof ring A could be followed by 0-methylation 
to produce structure (58), The involvement of berberastine in
34 35the biosynthesis of macarpine has been shown for Hydrastis 
canadensis in bu , series of labelling experiments: this would 








Again, these derivatives are assumed to arise from the 
mechanism postulated above. Circumstantial evidence is provided 
by the occurrence of the compound (62)
(62)
with corynoline (25) and corynoxoline (30) in the plant
10,36Corydalis incisa.
Two in-vitro routes to 13-methyldihydroprotoberberines are 
known, one involving méthylation of the 1—benzylisoquinoline
37 38
precursor, the other a méthylation of the dihydroprotoberberine,
28
28the latter being preferred as a model for biosynthesis. Tracer
39experiments are inconclusive.
29
STRUCTURE AND STEREOCHEMISTRY 
Structure of fully unsaturated compounds
The structures of sanguinarine (6), chelerythrine (7), 
chelidonine (20) and homochelidonine (21) were elucidated by 
classical degradative techniques in the 1930s by Bruchhausen 
and Berch and by Spath and Kufner, and have been the subject of
L 2 ^ ^ 3 M  45/6several reviews. All have been confirmed by synthesis.
The structures of avicine (S) and nitidine (9) have also 
been elucidated by degradative techniques, by Arthur, Hui and 
Ng^ Confirmatory syntheses have been carried out^^^^
More modern techniques have been used in elucidation of 
the structure of bocconine (24) by the comparison of the proton 
n.m.r. spectrum of its 5,6-dihydro derivative with that of 
dihydrosanguinarine and dihydrochelerythrine. This still left 
some doubt as to the substitution in Ring A but use of the 






H 3 C O V
1 11 1
—  + 'x :h -
(17 (15)
since irradiation of the methoxy signal led to an increase in 
the Ring A proton resonance but had no effect on the resonance 
of the C-11 proton.
URecent work by Ishii and his group has, however, shown 
that (17) is the correct structure and that (17) and 
chelirubine (15) are also identical. This re-assignation was 
again done using proton magnetic resonance but was also 
supported by an unambiguous synthesis of oxychelirubine (I7a), 
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CH 3 CH3 
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The structure of the four compounds, chelirubine (15), 
chelilutine (16), sanguirubine (13) and sanguilutine (14) were 
originally assigned on the basis of their infra red spectra and
49these were later corroborated by Slavik, who examined the 
proton n.m.r. spectra of the 5,6-dihydro-6-cyanide derivatives. 
The work by Ishii on chelirubine must cast doubt on the 
structures of the other three compounds and also on the 
dimethoxy alkaloid macarpine (19). These compounds remain to 
be investigated.
32.
structure of partially unsaturated compounds
The structural and stereochemical implications of the
partially unsaturated alkaloids are well illustrated by
chelidonine (20), The classical degradative work was carried
1.0out by Bruchhausen and Bersch,
The molecular formula was found to be CggH^gNO^HgO and 
was found to comprise two methylenedioxy groups, one N-methyl 
group and one hydroxyl group; the carbon skeleton was identified 
when benzo(c)phenanthridine was obtained after distillation of 
the alkaloid with zinc dust. Oxidation of chelidonine with 
potassium permanganate gave a mixture of 3,4- and 4,5-methylene- 
dioxyphthalic acids (63) and (64)
Hofmann degradation gave a methine which was degraded by 
potassium permanganate to 4,5—methylenedioxyphthalic acid and 










From this evidence it was possible to infer the part structure 
(66) for the methine
(66)
and the part structure (67) for chelidonine.
(67 )
I- -OH
—  — OH
This leaves only the position of the hydroxyl group and 
the orientation of the B-C ring junction to be decided. Since 
the hydroxyl group possessed no phenol properties it must be on 
ring B or C. Positions 6 and 14 were discounted since no 
carbinolamine properties were apparent and position 13 because 
the hydroxyl group was retained in the methine.
34
Thus the hydroxyl could be situated at either C11 or C12, 
both of which would give similar reactions.
Oxidation of chelidonine by mercuric acetate gave a mix­
ture of products including didehydrochelidonine, recently ident­
ified by Benn and Mitchell as (68),fCan. 3 Chem., 1969, 47, 
3701.]
Overall the chemical evidence supports the structure (20) 
with the hydroxyl group at C-11. Proper confirmation of this
51was obtained by Berch by considering the IR spectrum which 
showed a strongly hydrogen bonded OH absorption. Bersch 
reasoned that this degree of hydrogen bonding was only possible 
if the OH group was in the C-11 axial position with the B and C
52 53 54rings cis-fused. This has since been confirmed by n.m.r.* *
studies which also showed that chelidonine adopted the half 
chair conformation.
The absolute stereochemistry of chelidonine was investi-
55
gated by Snatzke et al using two methods. The first method was 
based on that originally developed by Horean, which correlated 
the absolute configuration of secondary alcohols with the 
kinetic partial resolutation during estérification with a 
Cx-phenylbutyric anhydride. An excess of (i)-«<-phenylbutyric 
anhydride was added to the optically active secondary alcohol. 





rotation measured. It has been shown empirically that if the 





then the recovered acid has the (S)(+) isomer in excess. Thus, 
chelidonine was found to be(71)
HO
(71)
This is equivalent to (71o) since the relative configurations 
are known.
37
This empirical study was supported by an analysis of the 
c.d. spectrum of chelidonine, in which the same conclusions 
were reached.
The final proof of the structure was provided by the total 
synthesis of (-) chelidonine carried out by Oppolzer and
56, ,
Kellar (qv). More recently the structures of corynoline (25)
, . 57and corynoloxine (30) were determined by Takao using degradative 
and spectroscopic techniques.
The molecular formula of corynoline was found to be 
^21^21 *̂^̂5 the molecule was found to contain one alcoholic 
hydroxyl group, one N-methyl, one 0-methyl group and two 
methylenedioxy functions. Corynoline was readily dehydrated to 
form deoxycorynoline (72) which was hydrogenated to 
dihydrodeoxycorynoline (73). Heating corynoline in vacuo at 
3GG°C gave the benzo(c)phenanthridine (74) with C-demethylation, 



























position of the methylenedioxy groups.
Removal of the hydroxyl group by chlorination and hydro- 
genolysis led to (75) which, after two Emde degradations gave 
the dimethyl compound (76), Heating (76) with selenium at 
300°C produced 2,3-methylenedioxy-6-methylnaphthalene (77): 
this fixes the C-methyl group at C13. The hydroxyl group was 
placed at C-11 by analogy with chelidonine. When corynoline 
was oxidised by aqueous potassium permanganate, corynoloxine 
(30) was formed. This (a) shows the relationship between the 
two natural products and with sanguinarine;(b) indicates that 
the B and C rings are cis-fused as in chelidonine. The fusion 
was also indicated by the intramolecular hydrogen bonding shown 
in the IR spectrum.
The stereochemistry has been considered by Naruto, Arakawa
54
and Kaneko and their proposals confirmed by an X-ray analysis
58of the p-bromobenzoate carried out by Kametani,
40
SYNTHESIS
Several approaches to the synthesis of benzo(c)phenanthridine 
alkaloids have been used since the first attempts early in this









ix) Total synthesis of chelidonine 
(intramolecular cycloaddition)
41
i )  C h ry s e n e q u in o n e
The route from Chrysenequinone (78) is of historic 
importance only, the original work being done by Graebe and
59Honigsberger at the turn of the century.
(78)
The amide (60) was formed by rearrangement of the oxime (79) of 
Chrysenequinone. On treatment with sodiumhypochlorite the 
amide produced the isocarbostyril (82) which in turn gave the 







50The route was further investigated by Badger and Seidler 
oho prepared the isocarbostyril from the amide using hydr&zoic 
acid.
As a route to the naturally occurring benzo(c)phenanthridine 
alkaloids this has several drawbacks, the main one being the 
considerable difficulty in producing chrysenequinone 
derivatives of suitable oxygen functionalisation.
4 3
i i )  B i s c h l e r - N a p i e r a l s k i
The Bischler-Napieralski approach is the next chrono­
logically and was the approach utilised by Robinson and his
51 52,63 2group, and later, by Govindachari et al, and Arthur and Ng,
Robinson's route to the 2,3,8,9-tetramethoxybenzo(c)- 
phenanthridine is shown in Scheme 2,
62,63
This type of ring closure was used by Govindachari et al to 
synthesise several 6-methylbenzo(c)phenanthridines and by
A7,6A 2Govindachari and his co-workers, and by Arthur and Ng, independ­
ently, to synthesise dihydronitidine (37).
R RO
R = H,CH3 
R = H , alkyl
It can be seen that all the derivatives described above 
have the same, symmetrical 2,3,8,9-oxygenation pattern and it 
has been found that in practice the Bischler-Napieralski 
approach does not lend itself to the synthesis of 2,3,7,8—
65oxygenated products. Indeed, the attempt by Robinson et al to 
produce the unsymmetrical compound by the introduction of a
uu
SCHEME 2




nuclear bromine blocking group produced the symmetrical product 






i i i )  H o m o p h th a lim id e  r o u t e
65,66This route was developed by Robinson after the unsuccessful 
attempts mentioned above to produce the unsymmetrically 
oxygenated benzo(c)phenanthridines by the Bischler-Napieralski 
route. In this synthesis the oxygenation pattern in the A ring 
is fixed by condensation of opianic acid (83) and the ketone (84) 
to give the phthalide (85), followed by a multistep synthesis to 










After polyphosphoric acid cyclisation of the homophthalimide to 





Two factors prevent the wider use of this synthetic route:
i) addition of potassium cyanide to the phthalide (85) 
forming the intermediate (89) prior to hydrolysis to the diacid 




ii) The catalytic reduction conditions used to form the
45,67,68
homophthalimide are sufficient to cleave some ethers, especially
^8
the cyclic methylenedioxy group. This severely limits the use 
of the route since it precludes the synthesis of a large 






i v )  1 , 2 - d i h y d r o i s o q u in o l i n e
Since it has been shown above that it is likely that 
chelidonine (19) is formed in-vivo via a 1,2-dihydroisoquinoline 
derivative it has occurred to several workers to attempt an
65in-vitro synthesis by this approach. Robinson attempted to 
convert anhydrocryptopine (91) to the benzo(c)phenanthridine by 
treatment with acid but this reaction was shown by Dyke and
69
Brown to give the 11-methyl-indeno(l,2-c)-isoquinoline (92),
(91) (92)
70,71In another piece of work. Dyke and his co-workers produced 









Although this reaction had been expected to produce the 
benzo(c)phenanthridines, Dyke and his team observed only 
disproportionation.
73,74
Dyke and his co-workers, using the 11-keto- derivatives
(94) of indeno-(l,2-c)isoquinolines, formed from the reaction 
of aromatic aldehydes with 1,2-dihydroisoquinolines followed by 
oxidation, attempted the diazomethane ring-expansion to the 
benzo(c)phenanthridines but met with no success.
(94)
Work carried out by this author on this reaction is described 
later in this thesis.
51
V/) Photochemical methods
Considerable work has been done on the formation of the 
benzo(c)phenanthridine skeleton by photochemical methods,
75particularly by the Japanese group of Onda, by Timmons and
76 77Loader and by Dyke and his group. Some success has been 
achieved although the method has yet to be used to advantage in 
the synthesis of the naturally occurring 7,8-dioxygenated 
compounds.
77The method of Dyke and Sainsbury utilised a 1,2-dihydro- 
isoquinoline. Condensation of the dimethoxybenzylaminoacetal






which, after sodium borohydride reduction and acid catalysed 
dehydration gave the styrene (98); irradiation in ethanol 
solution gave 2,3,8,9-tetramethoxybenzo(c)phenanthridine in 30% 
yield.
Dyke and Sainsbury used the same method to produce the 
much less favoured 2,3,7,8—tetramethoxybenzo(c)phenanthridine 
in extremely low yield. Using a similar approach, Loader and
76Timmons produced the basic skeleton from the styrene (99).
(99)
75The route developed by Onda and his group, while not a 
synthesis ab-initio, illustrates that although the unsymmetrical 
compounds are in general difficult to prepare photochemically, 
they can non theless be prepared from suitable precursors.
Onda started from the natural product protopine (100) and, 
by Hofroana degradation, produced the vinyl compound anhydro- 
protopine (101 ),
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/ " W o
CH^I
CH3OH/KOH
^ H 3  ( 1 0 1 )
Irradiation produced an unstable compound, supposed to be a 
benzo(c)phenanthridine with an unknown degree of saturation in 
the B and C rings, which was not isolated. On dehydrogenation 
5,6-dihydrosanguinarine (25) was isolated and this in turn was 
oxidised to the fully aromatic compound, sanguinarine,
Onda put forward three structures for the intermediate and 
offered spectroscopic evidence for the 5,6,11,12~tetrahydro- 
benzo(c)phenanthridine (102) formed by isomérisation of the 
initial cycloaddition product (103),
(102) (103)
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Evidence was provided for structure (103) by the isolation 
of the Diels-Alder adduct (104)
IO2C2H5
(104)
formed by addition of diethylacetylenedicarboxylate to the 
reaction mixture.
In another example of this type of synthesis Onda and 
Kawakami synthesised the dihydrochelerythrine derivative (105) 
from 1-oc-narcotine (106), Reductive cleavage followed by re— 
cyclisation gave the dihydroprotoberberinium salt (107) which, 
on treatment with methanolic potassium hydroxide, produced the 
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A simple synthesis of N-norchelerythrine (ill) h§s been
79
developed using this approach by Manske et al starting from 
(-)-ophiocarpine (109), the initial
CH
( 1 1 1 )
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r ^  1 Y  KOt-Bu ^
s. ,N  ^ ,j  PhCOPh , , ^ J
(110)
C H z N ?
CH
(1 1 1 )
ring cleavage to the methine (110) being brought about using 
modified Oppenauefconditions. Essentially the same method has 
been used by Onda to produce a mixture of the tuo13-methyl
57









v i  ) Is o c o u m a r i n
iso co u m a rin
■ The potential of a synthetic approach involving the replace­
ment of the oxygen atom of suitably substituted isocoumarin 
derivatives by nitrogen has long been recognised. Initial work
45was carried out by Bailey and Worthing who converted the diacid 
intermediate (116) formed in the Robinson homophthalimide route 
into the isocoumarin (117),
0 CH3
(116) (117
The isocoumarin thus formed was heated with a mixture of 
ethylene glycol and ammonia and gave oxychelerythine (IIB),
5 9
(118
Considerable work has been carried out in this laboratory 
directed towards the utilisation of isocoumarin derivatives in 
the synthesis of naturally occurring benzo(c)phenanthridine 




Dyke et al tried unsuccessfully to produce the partially reduced 
benzo(c)phenanthridine skeleton using both ammonia under pres­
sure and ethanolic ammonia; the former conditions giving only 
2-phenylnaphthalene, the latter 2-(B-naphthyl)benzoic acid.
%
Further work by Wiggins was carried out on the 3-aryl
60
isoguinolines produced by nitrogen substitution of the 3-aryl 
isocoumarins formed by the reaction of homophthalic acid, 
catechol and stannic chloride.
Refluxing with ethanolic methylamine followed by reaction with 




After further exploratory work it was found that the 4-formyl 
derivative could be formed by a Uilsmeieftype of reaction after
61
reduction to the 1,2-dihydroisoquinoline (121, R=H),
€H
(121
However, substitution of dimethylacetamide for dimethylformamide 
in the Vilsmier reaction did not produce the desired 4-acetyl 
derivative (121, R=Me). Introduction of the second carbon atom 
(the benzo(c)phenanthridine C-12 atom) was eventually achieved 
by the introduction of a cyanide group. This was carried out 
by treating the methoxyiminiumether (122) formed by reaction of 
the 4-formyl derivative with triethyloxonium tetrafluoroborate 




Direct ring-closure of the cyano compound (123) under acid 
conditions was attempted but cyclisation failed to occur.
Modifications to the cyanide function were also investig­
ated, for example, reduction to the amine as a first step 
towards Pschorr ring-closure. Several reduction techniques, 




There are two possible applications of the Pschorr reaction 
to the synthesis of benzo(c)phenanthridine compounds: 
a) formation of ring B
b) formation of ring C
61 82 68 The former application used by Robinson, Noller, Haworth and
83
Govindachari was unsuccessful due to preferential attack by the 
radical intermediate of the naphthalene 1-position forming 





If the nitrogen holds a group, for example benzyl, which will 
cause some hindrance to attack at the naphthalene 1-position
84
then attack at the naphthalene 2-position can occur, viz:
The more successful approach using the Pschorr reaction is
85
that pioneered by Abramovitch and Tertzakian and subsequently 
developed into an elegant synthesis of sanguinarine chloride by
86,87 , ,Dyke and his group, in which the benzo(c)phenanthridine ring C 
is completed by Pschorr ring closure.
65
In the original synthesis of benzo(c)phenanthridine by 
Abramovitch and Tertzakian isoquinoline-4-acetic acid (125) 
(made by a multistage synthesis) is converted into the amino- 






Cyclisation under Pschorr conditions followed by decarboxylation 
gave benzo(c)phenanthridine (128).
Thecfefect of the synthesis, subsequently overcome by Dyke 
et al. is the multistage synthesis of isoquinoline-4-acetic
6 6
acid: this was only achieved in low yield and not even attempted
68for oxygenated analogues. Dyke et al. noted the known conden­
sation of N-benzylaminoacetals with aryl aldehydes to give 
4-substituted isoquinolines, for example:
h^CO 0CH3
and examined the condensation of aminoacetals with glyoxylic 
acid: this was found to give an easily separable mixture of 
isoquinoline 2- and 4-acetic acids:
H3C 0 0 CH3
N. .COoH + ^
67
Reaction with suitable oxygenated aminoacetals allowed the syn­














Little use has been made of this reaction and the extreme 
reaction conditions used to generate some aryne intermediates 
make it unlikely that it will find much utilisation in syntheses 
aimed at compounds containing the sensitive methylenedioxy func-
%9
tion. However, Kessar and his co-workers have produced the
3,4-dihydro-8-methoxybenzo(c)phenanthridin-1(2H)-one (129) by 







Also, Kametani and his co-workers have produced nitidine 
(9), albeit in low yield, from a benzyne reaction. The key 
intermediate tetralone (133) was formed by reaction of
3,4-dihydro-6,7-methylenedioxy-1(2H)naphthalenone (131) and 
1-bromo-3,4-dimethoxybenzene (132) with sodium amide in 
refluxing dry tetrahydrofuran.
' < ^ ^ 0 C H 3
(132)
OCH




(133) was converted to the amine (134) via the oxime, and a 
Mannich reaction gave the benzo(c)phenanthridine (135) which 





The mechanism of this type of reaction makes it unlikely 
to be used for unsymmetrically oxygenated analogues since the 
benzyne coupling will always take place meta- to an oxygen. 
This would have occurred even if, in this case, 1-bromo-2,3- 
dimethoxybenzene had been used.
71
91This difficulty has been overcome by Stermitz et al. in 
which the key intermediate is the 1-aminonaphthalene (l36a),
a X=H R^=R2=H 
b X=0 R^sRg^H 
c X=H R^sC^H^RsCH^ 
d X=H R^=CHg R2=CgHy
which was obtained by reduction of the nitro compound (I36b) 
formed by acetyl nitrate nitration of the bis mesyloxy— 





Reaction of (I36c) with the bromoaldehyde (138)





which was converted to the aromatic N-norbenzo(c)phenanthridine 






standard aklylation methods gave the salt (141)




Fagaronine (142) was produced by removal of the Isopropoxy 
protecting group by treatment with HBr/acetic acid.
^  + ̂ C H 3
143)
lu




ix) Total synthesis of chelidonine
A total synthesis has been carried out by Oppolzer and
56.Kellar in which the stereoselective skeleton forming step is the 
thermolysis of the compound (48).
X
1144)
Although thermolysis of the amide (144, R=H,X=0) led to the 
trans fused product (145), similar treatment of the urethane 
(144, R=C02Me,X=H2) produced the cis fused product due to 
greater structural flexibility (146).
1145 (146)
7 6
Using the simple building blocks (147) and (148)




the urethane (149) was formed by reaction of the sodium salt of 
(147) with (148) in dimethylformamide.
H7C7O2C
(149)
Subsequent transformations are set out below, Bromination 
followed by dehydrobromination gave the acetylene (150) which 
re-arranged to the tetrahydrobenzo(c)phenanthridine (151), 
Hydroboration followed by oxidation with hydrogen peroxide gave 
the alcohol (152) as a 1:1 mixture of epimers which were easily 
separated by column chromatography. Oxidation of (152) gave 
the ketone (153) which was stereospecifically reduced with 
sodium borohydride in methanoldioxane to the cis, cis alcohol 
(154). Hydrogenolysis gave dl-norchelidonine which was easily
77
converted by N—méthylation to dl.-chelidonine which was identical 













During the last century over eighty epidemics of dropsy
92have been recorded in India; other epidemics of the disease in 
other tropical areas, notably the West Indies, Mauritius and 
tropical Africa, have been recorded^Suring this period although 
these have been apparently less severe than the Indian out-
95breaks. The last recorded epidemic occurred in Bombay in 1966 
and affected several hundred people and a major epidemic of 
1935 affected 7,000 people of whom 1,500 died. The vast size 
of India and the remoteness of some areas suggest that the 
number of recorded epidemics could be only a fraction of the 
total.
The usual symptoms of epidemic dropsy are swelling of the 
legs and extremities coupled with gastro-intestinal disturb-
92 96ances. An anaemia condition can also occur. Post mortem 
examination of most body tissue shows histopathological changes
97to have taken place, A review of the historical data shows 
that a symptomless form of glaucoma was first noted in epidemic
98
dropsy cases by Maynard in 1909. The condition was charac­
terised by:
i) increased intraocular pressure 
ii) dimmed vision with haloes 
iii) corneal oedema 
iv) retinal haemorrhage 
v) field loss unless the pressure was relieved surgically
80
or as a result of general recovery from the dropsy condition. 
There is usually no inflammation or pain. Cupping of the 
retina and atrophy of the optic nerve usually occur late in the 
course of the disease, the victim not knowing the extent of the 
disease until the onset of partial or total blindness.
Glaucoma
Glaucoma is normally defined as a blinding disease local­
ised in the eyeball in which the intraocular pressure of the 
anterior chamber is raised considerably by either over-secretion 
of aqueous fluid or by blockage of the normal drainage canals. 
This can be by anatomical, physiological or pathological means, 
or a combination of all three. Its effects are usually miti­
gated by physically relieving the pressure by the creation of 
artificial drainage canals (IRIDECTOMY). Normal eye pressure 
is 15mm. Hg. with some diurnal variation.
Arqemone glaucoma
99Initial symptoms are fluctuations in eye pressure of up to 
70mm., later stabilising at a higher pressure. A gradual
100J01diminution of vision is also experienced. Unlike many glaucoma 
conditions, this is not initially accompanied by the usual 
nausea, vomitting and pain: the most obvious symptom to the
99patient is the diminution of vision caused by atrophy of the 
optic nerve when the disease is in its later stages and irre-
92versible damage already done. Eyes show no inflammation,
81
although post mortem examination of poisoned subjects revealed
102-106retinal haemorrhage and degeneration, particularly in senile 
cases.
The connection between the outbreaks of "epidemic" dropsy 
(and its associated conditions such as glaucoma) and adulterated 
or contaminated vegetable oils was first noted, in India, by
107Sarkar who discovered that all the victims of an outbreak had 
consumed oil from a press which had previously been used for 
extracting Argemone mexicana seed oil.
Since then, argemone seed oil has been implicated in most 
of the outbreaks where forensic investigation has been possible.
In one recent outbreak, victims were asked to provide
108,109samples of cooking oil for analysis: sanguinarine was detected 
in most cases, implying adulteration or contamination by 
Argemone seed oil.
Sanguinarine has been detected in the blood and urine of
argemone poisoning victims, both by this author (qv) and by
108,110others.
111
Sanguinarine was detected in the placenta of an argemone 
victim who aborted during the course of her illness; this is a 
common symptom and has been noted in humans, laboratory animals
82
111
and farm animals. It is appreciated by the Ministry of 
Agriculture, for instance, that grazing on Chelidonium majus 
(greater celandine) can cause spontaneous abortion in cattle.
It should be borne in mind that due to the social and 
religious conventions of India the consumption of non-animal 
fats is very high and consequently the extraction and marketing 
of vegetable oils and vegetable oil products is a major 
commercial undertaking. At the same time, the extent of 
organised and intensive agriculture dictates that the culti­
vation of edible oil crops be almost a "cottage industry" with 
much of the cultivation being on smallholdings and collection 
being on a local and regional basis. It can be appreciated 
that there is plenty of scope for adulteration given a prolific 
weed such as Argemone mexicana with a high seed-oil content, 
this being up to 30/S by weight of the seed. It is improbable, 
of course, that this adulteration is done with the connivance 
of the oil producing companies since the relationship between 
gross adulteration of argemone oil and dropsy epidemics is now 
well documented and accepted. The tests adopted by the oil 
companies are, however, so insensitive and imprecise as to 
suggest that they are only interested in reducing the level of 
contamination rather than eliminating it altogether.
The ingestion of small amounts of sanguinarine over long
112periods of time has been suggested by Hakim as a possible cause
83
of endemic glaucoma as opposed to the epidemic form mentioned 
above. Endemic glaucoma is a disease of enormous world wide 
proportions. In the United Kingdom, one per cent of the popu­
lation over the age of 40 years is a glaucoma victim and a
113large proportion of these cases result in total blindness.
Similar statistics apply in most developed countries. The 
situation in the undeveloped world is, of course, open to 
speculation although since some protection is obtained from a 
high—protein diet one would expect the position to be much 
worse.
Hakim suggests several ways in which sanguinarine can be 
innocently ingested over long periods of time. Obviously, 
edible oil products with low level contamination is an obvious 
choice in countries where this is possible.
114
Hakim has shown that ingestion of the foliage of Argemone 
mexicana led to the presence of sanguinarine in the milk of 
goats and cattle. This also occurred when the animals were fed 
with oil-seed cake containing argemone seed. Sanguinarine was 
also concentrated in the flesh (particularly the liver) of 
animals which had been allowed to feed on A.mexicana foliage.
(Studies with poultry showed that when hens were fed on corn 
containing argemone seed,sanguinarine was detected in the eggs.
84
Feeding of the contaminated milk or eggs caused rises in 
intraocular pressure in experimental animals. It is quite
115possible that ingestion of contaminated dairy produce over a 
long period of time could lead to glaucoma in later life.
It may be objected that sanguinarine is a rare alkaloid
unlikely to appear in a Western diet and until recently this
was believed to be the case. It now appears, however, that
sanguinarine is an extremely common alkaloid and some screening
112work by Hakim, Mijovic and Walker indicates that it is probably 
present, although in small quantities, in most of the 575 
species of Papaveraceae, a plant family which, of course, has 
world wide distribution.
Table 7 shows the occurrence of sanguinarine and other 
benzo(c)phenanthridines in species of Papaveraceae found in the 
United Kingdom, It is true, of course,thatwKere good pasture 
exists animals would tend not to feed on papaveraceous plants 
but in certain areas of the world this is not possible due to 
the preponderance of plants of this family.
116
other routes to ingestion exist: Argemone foliage is
eaten as a salad vegetable in parts of India and Iran (as is 
the foliage of Papaver somniferum in areas where this plant is 
cultivated). Argemone roots are used to prepare a fermented 
beverage in parts of Africa and Argemone oil is used as a
85
purgative in Africa and India.
Sanguinarine can be directly ingested by the use of 
culinary poppy seed, which have been found by several authors 
including this author to contain sanguinarine, which is often 
sprinkled on bread or incorporated into poppy seed cake. Some 
cultural groups, for example the Dewish community, make 
considerable use of poppy seeds in cooking and a higher than
117usual incidence of glaucoma has been noted for these groups.
Of most relevance to the developed world is the ingestion
of sanguinarine through contaminated dairy and meat products.
Some preliminary work in correlating glaucoma distribution with
the geographical distribution of papaveraceae and of climatic
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Corydalis lutea Linn 
C.claviculata Linn.
F X X X X




Crantz FAB X X X X
G.comiculatum Linn. F X X X X
Eschscholtzia cali- 
fornica Cham. F X X X X
Meconopsis cambrica 
Linn. FAB X X
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KEY TO TABLE OF BRITISH PAPAVERACEAE
Citations
The plant species listed are cited in at least one of 
the three major Floras:
F = Flora Europaea Cambridge University Press
A = Atlas of British Flora Ed. Perring & Walters
B = British Flora Bentham & Hooker
Some differences of classification occur:
F.vaillantii Loisel = F.parviflora Linn, in ‘British Flora* 
F.muralis ss muralis Koch = F.capreolata Linn, in ‘British Flora* 
F.micracantha Lag. = F.densiflora DC in ‘Flora Europaea*
P.dubium Linn. = P.lecoqii Lam. (Index Kewensis)
Abundance






A considerable amount of work on the pharmacology of the 
seed oil of Arqemone mexicana Linn, and sanguinarine was carried
. 92out by Hakim, corroborating and developing the earlier studies
119of Meyer. His findings can be summarised thus;
i) sanguinarine depresses the actions of sympathetic 
stimulation and of adrenaline
ii) sanguinarine stimulates, then subsequently 
depresses, adrenaline-like actions 
iii) adrenaline reduces or abolishes the action of 
sanguinarine 
iv) the action of acetylcholine is decreased by 
sanguinarine.
In the same paper Hakim describes some biochemical effects 
of sanguinarine. In a series of experiments he found that 
i) sanguinarine enhanced the action of insulin
ii) sanguinarine did not cause a significant increase in 
blood pyruvate levels in rats
iii) sanguinarine inhibits cholineacetylase in in-vitro 
experiments.
The fact that sanguinarine does not cause a significant 
increase in blood pyruvate levels was unexpected, since blood 
pyruvate levels were known to be higher than normal in Argemone
89
1 2 0oil dropsy cases and it has been shown that sanguinarine is
toxic to several physiological enzyme systems including pyruvate
oxidase. Hakim rationalises this by assuming pyruvate oxidase
blockage to be a symptom of high-dose acute poisoning, although
120no evidence is offered. Previously, Sarkar had found that 
sanguinarine chloride inhibited the in-vivo oxidation of 
pyruvate, succinate and lactate and suggested that the inhibit­
ory effect of sanguinarine is due to its action on -SH enzyme 
systems. This theory is substantiated by the observation that 
although BAL (British Anti Lewisite, 2,3—dimercaptopropanol) 
(155) would not reverse the effects of sanguinarine; pretreat­
ment with BAL gave effective treatment. Further evidence is
provided by the observation that epidemic dropsy generally
121
affects populations with low protein diets, particularly where
the intake of cysteine is low. Goats fed argemone oil
incorporated in a low cysteine diet were affected to a greater






In an experiment to investigate the effect of Sanguinarine 
on the drainage mechanism of the anterior chamber of the eye 
Hakim perfused the anterior chamber of an isolated ox eye with 
an artificially compounded ox aqueous fluid through a fine bore 
needle. Addition of a dye to the perfusing fluid indicated 
normal drainage through the filtration angle. Addition of 
sanguinarine chloride or Argemone seed oil immediately stopped 
the outflow of dyed aqueous fluid for periods of up to thirty 
minutes. Direct injection into the anterior chambers of the 
eyes to live animals had the same effect, as shown by a rise in 
intraocular pressure. Subsequently this phenomenon was demon­
strated with chelerythrine (7) and with oils and latexes from 
several other species of Papaveraceae,
123The work was taken further by Liebe and Scherf, who found 
that intravenous injections of other isoquinoline alkaloids 
produced similar acute rises in intraocular pressure. The 
isoquinolines found to exert this effect are shown in Table 8,
91
TABLE 8












♦Alkaloids reported in A.mexicana Linn.
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In an elegant development of his work, Hakim produced 
increases in intraocular pressure by direct stimulation of the 
hypothalamus area of the brain with sanguinarine. This approach
125had been suggested by the work of Sallman and Lowenstein and of 
126Gloster and Greaves who had produced increases in intraocular 
pressure by electrical stimulation of the hypothalamus.
It appeared likely that a neurohormone, whose release 
could be triggered either by pharmacological or electrical 
means, was responsible for the increase in intraocular pressure,
Hakim reasoned that a neurohormone released into the eye of 
an experimental animal could be used to stimulate increases in 
intraocular pressure in a second animal. An experiment was
115designed which was similar in approach to those described by
127 128Bain and by Loewi, In these classical experiments, two 
isolated, beating, frog hearts were perfused in series; 
stimulation of the vagus nerve of the first heart led to the 
release of acetylcholine which slowed the beating of both 
stimulated and recipient hearts. Hakim perfused the left eyes 
(in situ) of two cats, in series, with saline.
The cornea of the first eye was pierced by a specially 
designed needle which permitted fluid to be continuously 
introduced to, and removed from, the anterior chamber after 
which it was dripped continuously onto the eye of the second
9 3
(anaesthetised) cat. Direct stimulation of the hypothalamus of 
the first cat, by introduction of sanguinarine chloride via a 
cannula, led to an increase in intraocular pressure in the 
second cat. The other eye of the recipient cat which was 
constantly dripped with saline as a control was not affected. 
Similar results were obtained when sanguinarine chloride was 
introduced to the donor cat as an intravenous drip.
Hakim postulates the existence of a ciliary-iris hormone, 
for which he proposes the name 'occulo-tensin’, which controls 
the aqueous pressure in the eye. He suggests that this hormone 
may be a prostaglandin (157) and that prostaglandin F^x(l50) is 





The evidence for this is largely circumstantial;
i) prostaglandins are components of the extracts of iris
129-132
material; Ambache extracted a mixture of prostaglandins 
Eg and FgO< from the rabbit iris and also from the cat
133iris. Anggard and Samuelsson have demonstrated the 
presence of protaglandin FgOC in the sheep iris
94
134ii) the effect of "occulo-tensin' was abolished by the 
enzyme 15-hydroxyprostaglandin-dehydrogenase in 
'double-cat' experiments (cf ref 103)
135
iii) the effect of 'occulo-tensin' was abolished by aspirin; 
this is a property typical of prostaglandins
135-137iv) prostaglandin is known to have the effect of
producing prolonged constriction of veins (in this case 
the effect would be on the subconjunctival aqueous 
veins which are part of the eye's drainage mechanism).
135
Hakim postulated a continuous secretion of prostaglandin Fg% 
in the eye in order to maintain constrictive tone in the 
drainage channels (thus maintaining a certain amount of 
necessary aqueous pressure in the tye). This is supported by 
the fact that aspirin, an acknowledged prostaglandin antagonist,
135
lowers the pressure in the normal eye.
The release of hormone is controlled by the hypothalamus: 
this explains the diurnal variation in eye tension in the 
normal eye and the fact that one of the initial symptoms of 
Argemone glaucoma is an increase in the range of the normal 
diurnal fluctuation, a consistent, permanent rise in eye 
pressure being a later development.
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Pharmacological and toxicological studies in several
138species of animal noted a difference in biological activity 
between sanguinarine chloride and Argemone mexicana seed oil, 
the seed oil being several times more active than could be 
explained by its apparent sanguinarine content.
Sanguinarine chloride, administered intravenously or
138aorally in doses lethal to rats was found to have no effect on 
rhesus monkeys although argemone mexicana seed oil in doses
138b
pro rata produced oedema. Similar amounts of argemone oil from 
which the alkaloids had been removed showed no biological 
effects. Furthermore, the effect of sanguinarine chloride ap­
peared to be transitory in many cases. It appeared likely to
139,140some workers that another compound was present in the seed oil, 
a potentiating factor, which, in combination with sanguinarine 
exerted the biological effect.
u o
In investigations by Rukmini a solid fatty acid was 
isolated by extraction of the oil with petroleium ether. The 
compound was found to be non-toxic as was the extracted 
argemone oil. However, when the two fractions were recombined 
or when sanguinarine chloride was combined with the fatty acid, 
normal argemone toxicity was again observed.
141
Chemical and spectroscopic examination suggest the compound 
to be (+)-6—hydroxy-6-methyl-9-oxo-octacosanoic acid (159).
96
OH 
C H2(CH2)/|g— 0 0 —  (CH2)2— Ç— (CH2) OO2H 
(159) CH3
(159a)
Elemental analysis coupled with mass spectroscopy showed 
the composition to be The compound formed a methyl
ester and an oxiMe and was optically active. The IR spectrum 
of the methyl ester showed the presence of a ketocarbonyl group 
(\)„J738cms-1 ); acétylation did not occur with pyridine/acetic 
anhydride but a mono-acetate was formed with perchloric acid/ 
acetic anhydride, indicating a sterically hindered hydroxyl 
group. Reduction with LiAlH^ produced a trihydroxy compound 
which in turn gave a triacetate with perchloric acid/acetic 
anhydride. Beckman rearrangement of the oxime followed by 
hydrolysis led to the recovery of the amine CH^CCHg)^gNHg
and an unsaturated dicarboxylic acid which gave isosebacic acid 
(159(>) on hydrogenation; this indicated that the carbonyl group 
was situated at C-9, subsequently confirmed by the appearance 
of a MacLafferty rearrangement fragment in the mass spectrum.
Dehydration of the methyl ester followed by oxidation with 
permanganate/periodate led to the isolation of glutaric acid.
97
which suggested that the hydroxyl group was situated at C-6.
It would appear from these observations that sanguinarine 
chloride requires the presence of a second compound before its 
full biological effect can be observed. Confirmation of these 
findings in well designed cross-over experiments in selected 
animals is required. In the absence of confirmation it may be 
that the difference in toxicity between argemoneoil and 
sanguinarine is apparent rather than real - if the dose is 
calculated on the amount of quarternary base extracted from the 
oil by conventional means then this could indeed be several 
times less than the amount of sanguinarine (as the pseudo base) 
actually present in the seed oil. Many workers including Hakim 
have assumed that the dihydrosanguinarine isolated from the 
seed oil is a bona fide constituent and not an artefact of 
isolation; since dihydrosanguinarine has been found to be non­
toxic 80-90% of the sanguinarine present in the oil may have 
been ignored. Another significant fact is that while all the 
toxicology and pharmacology of sanguinarine has been carried 
out on the quarternary salt, usually the chloride, in the real 
situation the alkaloid is presented to the system as the 
tertiary (pseudo) base and this raises several questions as to 
the validity of any simple comparisons between argemone oil and 
sanguinarine chloride in in-vivo situations. Comparisons using 
oral administrations are particularly suspect.
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ANALYTICAL DETERMINATION OF SANGUINARINE
Since the involvement of Argemone oil and sanguinarine in 
epidemic dropsy was well established and its role in endemic, 
chronic glaucoma supported by a growing body of circumstantial 
evidence an analytical method mas required that could detect 
and estimate sanguinarine in low concentrations in edible oils, 
food products and physiological fluids and tissue.
As it was hoped that the final estimation method would be 
used as a routine screening procedure for suspect foodstuffs and 
for suspected cases of argemone poisoning it was essential that 
the method be simple, rapid, and use the minimum of sophisti­
cated equipment. A further important consideration was that the 
procedure would probably need to be carried out by semi-skilled 
personnel.
Several methods exist for the detection of adulterated 
edible oils. Those recommended by the Indian authorities are 
simply qualitative procedures which indicate the presence of 
sanguinarine but not the extent of the contamination. In one
142procedure a sample of the oil is treated with hydrochloric acid 
and ferric chloride; where sanguinarine is present red/brown
143crystals appear at the interface. In an alternative test a 
sample of oil is treated with hydrochloric acid: sanguinarine 
is extracted into the acid aqueous phase and imparts a red 
coloration.
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Neither procedure gives a conclusive result when the 




b) specific for sanguinarine.
Analytical procedures involving paper chromatography have
112X144 145 146been described by Hakim and by Chakravarti et al, and Hakim has 
also described an electrophorelic technique. A method employing 
thin layer chromatography of the gross oil sample has been
147described by Verma et al. All the methods above are simply 
detection procedures which give no quantitative estimation of 
alkaloid content,
148A colorimetric procedure described by Bose, in which the 
colour developed by addition of antimony trichloride is 
measured, claims to be quantitative but has several defects,not 
least of which is that at no point in the procedure is a 
solution diluted to standard volume!
It can be said, therefore, that the existing methods are 
nonquantitative or, at best, semiquantitative.
The main problem encountered in the analysis of 
sanguinarine is in the initial extraction of the alkaloid.
1 0 0
Phytochemical investigations carried out both by this author 
and by others have shown that 95-100 per cent of the alkaloidal 
material obtained from the seed oil of Argemone mexicana is a 
mixture of sanguinarine (6) and dihydrosanguinarine (31) the 
proportions are variable but dihydrosanguinarine predominates, 
being 80-90 per cent of the mixture. Dihydrosanguinarine has 
been found by Hakim and Sewkar to be non toxic and so at first 
sight it would appear that the toxic principle sanguinarine is 
a relatively low (10-20 per cent) fraction of the total 
alkaloids present. It is generally accepted, however, that 
dihydrosanguinarine is an artefact of the extraction procedure, 
produced by the disporportionation of the pseudo base of 
sanguinarine ( 5 ), This reaction is known to occur in-vitro 
when sanguinarine salts are treated with aqueous base:
H OH
The disproportionation reaction then proceeds, two molecules 
of the pseudo base producing one molecule of oxysanguinarine and 
one of dihydrosanguinarine. It is conceivable that this is an 
intermolecular reaction involving transfer of hydrogen with its 
electron pair.
1 0 1
r X H 3
c
This would have to occur in a concerted manner in a 
bimolecular complex since migration of free hydride tons is 
unlikely in aqueous media. It can be seen that this type of 
reaction could take placenot only during the later stages of a 
classical base work-up procedure but also in the early stages 
since sanguinarine is present in the plant as a pseudobase - 
sugar conjugate and not as the quarternary salt. Initial 
hydrolysis of the pseudobase-sugar conjugate could also lead to 
disproportionation products.
f C " '
1 0 2
Thus, any analysis procedure must be capable of either 
extracting and assaying sanguinarine plus the sanguinarine 
derived products dihydrosanguinarine and oxysanguinarine which 
would be very difficult, or of transforming the sanguinarine 
in situ into a compound with properties suitable for extraction 
and estimation.
It was realised relatively early on that direct extraction 
and estimation of sanguinarine based alkaloids was not a prac­
tical proposition. It was decided, therefore, to modify the 
sanguinarine in situ and avoid interference by artefacts.
It was thought that the simplest way to facilitate total 
extraction of the alkaloid and to improve its stability during 
analytical manipulation was to reduce the alkaloid to the 
5,6-dihydroderivative, a simple reaction using sodium
149borohydride. Complete removal of the tertiary base would then 
be possible using simple extractive techniques.
Initially the oil was treated with a solution of sodium 
borohydride in ethanol, with rapid shaking of the resulting two 
phase mixture. After the reaction was complete, ether was 
added, and the mixture extracted with acid. Normal base work­
up led to the recovery of dihydrosanguinarine. Unfortunately 
this method gave results which were very variable, indicating 
a problem due to the non-homogeneous nature of the reaction 
medium.
/  -  '  's
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In order to homogenise the reaction medium it was necessary 
to choose a solvent which dissolved argemone seed oil and at the 
same time fulfilled the conditions for reduction with sodium 
borohydride, that is, the solvent must be capable of releasing 
protons. This meant that the search be confined to the lower 
alcohols and it was found that n-propanol was the most suitable, 
A solution of argemone oil in n-propanol was treated with a 
solution ofsodium borohydride in n-propanol. After reaction the 
n-propanol was removed under reduced pressure, the residue 
dissolved in ether and worked—up for bases. This method gave 
higher mean recoveries than obtained previously but still a 
considerable amount of variation occurred and it was felt that 
this was due to incomplete dissolution of the residue prior to 
extraction or to reaction with the n-propanol during its removal 
since relatively high temperatures were required for complete 
removal.
It was then realised that ethanol was slightly soluble in 
petroleum ether (40°-60°), It was possible, then, to produce a 
’’solution" of sodium borohydride in ethanolic petroleum ether. 
Since seed oils are also soluble in petroleum ether this would 
be expected to give a homogeneous reaction medium and this was 
found to be the case.
Two methods of analysis of the extracted alkaloid were 
actively pursued, the first being a gas chromatographic method
) L
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by which it was hoped to simultaneously detect sanguinarine (as 
a derivative) and benz(c)acridine, its proposed metabolite 
(q.v.). This was found to be unsuitable for sanguinarine but 
provided a rapid analysis for benz(c)acridine, and is described 
in Chapter 3,
The thin layer chromatographic method eventually developed 
combines a rapid screening technique, non-quantitative detection 
down to very low levels and an accurate and precise determination 
within defined limits. The method can be applied to oil 
samples, tissue samples and physiological samples such as milk, 
urine, and blood (after concentration). With some initial pre- 
treatment foodstuffs could also be examined.
Summary
The method consists of the reduction of sanguinarine by 
sodium borohydride to 5,6-dihydrosanguinarine followed by 
extraction into aqueous acid media; basification and extraction 
with chloroform is followed by concentration to standard volume. 
Samples are applied to a thin layer (250^) of silica gel G by 
either a microsyringe or precision microcapilliary and, after 
presaturation, developed over 10cm with a mixture of benzene 
and methanol. Irradiation of the air-dried plate with long 
wavelength untra-violet light caused reoxidation to the fully 
aromatic benzo(c)phenanthridine.
After removal of the tic spot using a specially designed
/ o
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micro ’vacuum cleaner' the sanguinarine was eluted from the 
silica gel absorbant with 95^ ethanol. After making up to 
standard volume with 95^ ethanol the absorbance at 330nm was 
measured. Comparison of the absorbance of the test solution 
with a standard curve allows the calculation of the amount of 





The processes leading up to the choice of the petroleum 
spirit/ethanol system have already been described. The extrac­
tion data for the three methods
a) Ethanol/oil (two phase)
b) n-propanol/oil (solution)
c) petroleum spirit/oil (solution)
are shown graphically, in the form of scatter diagrams in 
Figures 1, 2 and 3, It can be seen that the amount of variation 
for the ethanol and n-propanol systems is unacceptable. Figure 
3, however, shows the method of choice to give good reproduce- 
able extraction of 95—3%, For data see Table 10.
Interference by other alkaloids
Several other alkaloids occur with sanguinarine in the 





A further minor alkaloid has been tentatively identified as 
N-norsanguinarine. Two other minor alkaloids occur in the oil 
but these remain to be identified. Of the four alkaloids 
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% s qng u i no ri n e e x t r a c te d
'""\!T ie th o d
e x p L " \ ^ (a) (b) (c)
1 65-0 80*0 97*0
2 60*0 61*0 97*5
3 51*0 85*0 94*0
k 66*5 70*0 96*0
5 63-0 63*0 93*0
6 80*0 78*0 97'5
7 56*0 53*0 94-5
8 63*0 61*0 92-5
9 A5-0 55-0 93*75
10 60*0 66*0 96*0
11 68*0 47*0 955
12 — 53*0 950
13 •-- — 945
MEAN 61*59 64*33 95*13
^ ( n - 1 ) 9*18 11*92 1*63
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the resolution of the two t.l.c. spots is not complete. In the 
particular case of Argemone mexicana seed oil this is not 
important due-to the difference in relative amounts present.
In other situations where the disparity is not so great there 
may well be difficulties since the difference between the two 
compounds is so small as to make total separation of the two 
extremely difficult.
In practical terms the separation would probably be imposs­
ible using the t.l.c. techniques but,since there is a slight 
difference in value,quantitative separation and estimation
of sanguinarine and chelerythrine may be possible using High 
Pressure Liquid Chromatography. It may, of course, be said that 
it is unnecessary to separate the two since their chemical and 
structural similarity would imply that both have the same 
physiological effects,
ii) Chromatography
Chromatographic conditions were established after 
considering several different solvent combinations. The use of 
aluminium oxide as absorbant was soon discounted due to the 
pseudobase transformations which were found to be taking place, 
and silica gel adsorbent chosen. The best separation was found
to occur using a mixture of benzene and methanol in the pro-
5 15
portion 6:1, although Slavic and his group and Stermitz have
done a considerable amount of identification work with benzo(c)-
phenanthridines using a 3:2 mixture. R^ was found to be very
112
dependent on the composition of the developing solvent mixture 
and it was also found that the adsorbent preferentially absorbed 
methanol. The result being that after a certain number of 
plates had been run the solvent mixture became depleted in 
methanol causing a drop in value. This problem was minimised 
by regular monitoring of solvent compositions.
The variation of sanguinarine with solvent composition











m e a n ‘s O' MEANT a
TANK 1 0-770 •021 0-782 •013
•’ 2 0-785 -034 0-790 •020
" 3 0*777 •024 0-785 -016
" 4 0*790 •029 0-790 -016
" 5 0-776 •022 0-780 •015
MEAN 0-780 -026 0-785 •016
a 0 '5 hrs, over benzene/methanol 
b 20  s a m p le s /p la te s
1 1 4
Comparison of the two sets of data in Table 11 shows that 
the reproduceability of the of sanguinarine was greatly 
increased by presaturation of the plates (after application of 
the sample spots) in an atmosphere of benzene and methanol.
This procedure also reduced the amount of methanol depletion of 
the solvent bath.
iii) Reoxidation
Reoxidation was found to be complete after fifteen minutes 
of ultra-violet irradiation. This reaction has also been
150
investigated by Stipanovic, Bell and Howell, who propose a free- 
radical reaction involving the free-radical (160) and the 
6-peroxy- derivative (161) formed by reaction of the radical 
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This was investigated by irradiation of plates for different 
lengths of time between 0 and 0,5 hours, samples being extracted 
off the plate as quickly as possible after the requisite time of 
irradiation. One 20 x 20cm plate containing 15 samples was 
examined for each time period. It can be seen from the graph, 
Figure 5, that the reaction is very fast, with 90% of the 
reoxidation being complete within five minutes.
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iv) Extraction
After development of the chromatogram it was found to be
necessary to include a drying stage to remove residual benzene
and methanol. Three methods were investigated: 
i) oven drying at 80^
ii) oven drying at 50°
iii) drying by cold air blast.
The results are presented in Figure 6. It can be seen that the 
two oven drying methods led to lower recoveries of sanguinarine 
than the cold air blast and the latter was adopted.
The removal of the developed sanguinarine spot was ac­
complished with the aid of the micro-suction apparatus shown in 
Figure 7: sanguinarine, absorbed onto silica gel was retained 
by the sintered glass disc, When all the adsorbent had been 
collected the apparatus was inverted, introduced into a standard 
5 or 10ml volumetric flask and the sanguinarine eluted off the 
adsorbent, into the flask by 95% ethanol with the aid of 
suction.
The manipulations were investigated by delivering a known 
amount of pure sanguinarine onto a silica gel plate, subjecting 
it to the drying conditions, and extracting with the micro­
suction apparatus. The u.v, absorbance of the resultant 
solution was compared with the u.v, absorbance of the same 
amount of sanguinarine delivered straight into the volumetric 
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FIGURE 7 




The results are shown in Table 12, It can be seen that the 
recovery off the plate has a mean value of 97.5% (range 95% - 
100%).
The experiment was repeated, this time comparing the 
absorbance of a known amount of sanguinarine delivered directly 
into standard flasks with that of the corresponding amount of 
dihydrosanguinarine delivered into the t.l.c. plate and sub­
jected to the oxidising conditions (15 minutes irradiation with 
long wavelength u.v. light) and then extracted. Results are 
shown in Table 13. Mean recovery is again 97,14% with a range 
of 95% - 101%.
A third series of experiments was carried out, comparing 
the absorbance of a known amount of sanguinarine with that of a 
corresponding amount of dihydrosanguinarine which had been 
spotted onto the base line of a 20 x 20cm t.l.c. plate, devel­
oped under the appropriate conditions, oxidised, dried and 
extracted. The results are presented in Table 14. Recovery 
was in the range 95% - 100% with a mean of 97%.
v) Determination of absorbance
Using pure sanguinarine chloride as a solution in 95% 
ethanol (acidified with one drop cone, hydrochloric acid) the 
adherence to the Beer-Lambert Law was investigated. A large 
number of replicates of different concentrations of sanguinarine 
were measured at a wavelength of 330nm.
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TABLE 12 







plate 0/  
control ^
5-0 4'90 4 65 95
10*0 9*82 9-62 98
15-0 1480 14-80 100
20-0 20’21 19*39 96
25-0 25'30 25*03 95
22-5 22-34 21*04 99
27-5 26-95 26-95 100
MEAN 97-57
measurement at 330 nm
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TABLE 13
Recovery of sanguinarine a fte r 









5'0 5*01 4 81 96
lO'O 9*87 9 55 97
15*0 14-95 14-22 95
20-0 20-05 19-84 99
22-5 22-32 22-54 101
25-0 24-80 24 04 97
27'5 27-20 2584 95
MEAN 97-14
medsurement at 330 nm
122
TABLE 14 
Recovery of sanguinarine a fte r  
a p p lic a tio n  as 5,6-dihydro sanguinarine^ 







5-0 4*96 4 .7 0 95
10.0 9*81 9-69 99
15-0 14-95 14*94 100
20-0 19-90 18-91 95
225 22-53 21-63 96
25*0 24-98 23.73 95
275 27-42 26.90 98
MEAN 96-85
measurement at 330 nm
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FIGURE 8
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TABLE 15 
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The data obtained is summarised in Table 15, and shown 
graphically in Figure 8. The data was found to give a very 
good straight line when concentration was plotted against 
absorbance (correlation co-efficient —  l OOO)
Thus, sanguinarine chloride was found to obey the Beer- 
Lambert Law in the range 0 - 4,0mg/l00ml,
vi ) Efficiency of method
Several experiments were carried out to investigate the 
overall efficiency of the method:
a) Known solutions of sanguinarine chloride were reduced, 
extracted, chromatographed and eluted,
b) Suspensions of sanguinarine and of dihydrosanguinarine 
were subjected to the complete extraction procedure,
c) Samples of argemone mexicana seed oil and of argemone 
mexicana oil diluted with vegetable oil were subjected to the 
complete analytical method.
The results of these three sets of experiments are shown 
in Tables 16, 17 and IB and in Figure 9,
It can be seen from the Tables that the method has a very 
high efficiency for the aqueous and ethanolic solutions of 
sanguinarine (97% - 4%) and a slightly lower efficiency for the 
oil samples (92% - 5%), This figure is however reproduceable.
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TABLE 16













15 2 10 15-10 14-04 93
15 2 10 15*10 14*65 97
10 2 5 lO'OO 9'50 95
10 2 5 10*00 9*50 95
7 10 10 6‘90 6-97 101
7 10 10 6*90 6-76 98
5 10 5 5*10 5'10 100
5 10 5 5*10 5-00 98
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TABLE 17
Suspensions of sa n g u in a rin e  ch lo r id e  and 

































2 0*98 0-88 90
10
0-025 20 10 0-26 0-23 91
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O01 20
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3 20 10 5 0*267 0*234 88
2 20 10 5 0*178 0*164 92
1 20 10 5 0-089 0*082 92
3 10 20 5 0*267 0*259 97
0 6 30 10 5 0'044 0*041 93
06 20 10 5 0*044 0*040 91
0-5 20 20 5 0*044 0*041 93













OO 1*0 2*0 30
A,mexicana concentra tion %  v/jv/
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vii) Sensitivity of Test
a, Non-quantitative
Sanguinarine exhibits an intense orange fluorescence 
under long wavelength ultra-violet light; using a 
combination of this and the value to identify 
sanguinarine it is possible, by a series of dilutions 
to identify the alkaloid at a concentration of 1ppm.
b. Quantitative
The lower useful limit is obviously dependent on the 
amount of sample available since this controls the 
amount of sanguinarine available for extraction, etc. 
The limit is set by the fact that the chromatograph 
sample must contain 10"^gm dihydrosanguinarine.
RAPID SCREENING PROCEDURE
A simple screening procedure was developed for rapid exam­
ination of the gross sample. It was designed mainly for 
screening oil samples but could be used with other fluids. The 
method uses the principle of two-dimensional chromatography on 
thick layers of silica gel, A sample of the oil is applied to 
one corner of a 20cm x 20cm thick (750^ ) plate and developed 
in benzene over 10cm, The plate is then removed, dried in a 
cold air blast, rotated through 90° and developed in a benzene/ 
methanol (6:1) solvent mixture. If present, sanguinarine 
appears as an orange spot of R^ co-ordinates (0,00, 0,70-0,80),
Samples giving a positive result would then be submitted
131
to the quantitative determination described above.
Examination of physioloqical material from cases of known 
Arqemone mexicana poisoninq
Samples of blood and urine were provided by Dr Hakim from 
one of his patients in a Bombay hospital. The patient, a young 
man named Haresh Adhyra, had been the victim of acute Argemone
151
mexicana poisoning. By examination of the material it was 
hoped to determine the persistence of sanguinarine after 
removal of the source.
Unfortunately, it was found that the samples were two 
years old when received and had been subjected to varying 
amounts of pretreatment. The material comprised blood and 
urine samples obtained over a period of two months, between 
August and October 1973,
Sanguinarine was found in low concentrations in the blood 
sample for August, but not subsequently. No sanguinarine was 
detected in the urine.
This finding may have some significance since it indicates 
that sanguinarine can remain in the blood-stream for between 
four and eight weeks, and that it is not readily metabolised or 
excreted. This lends some support to the theory of Hakim that
132
sanguinarine is "trapped" in the system and circulated, being 
absorbed through the gut, circulated through the blood and then 
secreted in the oesophagus* Sanguinarine has been implicated 
in the genesis of cancers of the stomach and oesophagus (q.v.). 
Results are shown in Table 19.
TABLE 19 
HUMAN PATHOLOGY 













1 17.7.73. 30 absent absent absen t
2 17. 8.73 90 present
3 undated 60 absent
9.73 20 •t





6 7.73 86 w
7 8.73 80 n
8 10.73 U »* 1#
9 undated 20 "
a ; t i c  method 
b: t i c  and glc
c; t i c
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MINOR ALKALOIDS OF SEED OIL OF 
ARGEMONE MEXICANA, LINN.
Seed oil (200g) was extracted with 95% ethanol (800ml) for 
several days, after which it was separated from the oil and the 
ethanol removed under reduced pressure. The residue, after 
dissolving in chloroform (200ml) was extracted with 2M hydro­
chloric acid (5 X 100ml). The combined acid portions were 
basified with sodium bicarbonate solution and extracted with 
chloroform (5 x 100ml). After washing with water (2 x 100ml) 
and drying over magnesium sulphate the chloroform was removed 
under reduced pressure to lea je a basic residue (600mg).
The residue was chromatographed on thick layers of silica 
gel (imm) using benzene/methanol (6:1) as developing solvent.
The upper 80^ of the orange sanguinarine band was removed and 
discarded; the remainder of the adsorbent was removed and 
extracted with 95^ ethanol. After evaporation of the ethanol 
under reduced pressure the residue was subjected to tic analysis 




Authentic samples were used as references. The alkaloids were 
visualised with ultra-violet light, removed from the plate
134
.using the micro ’vacuum cleaner’ and eluted with ethanol. 













identical with authentic samples.
QUANTITATIVE DETERMINATION OF SANGUINARINE
The sample of oil (A. mexicana seed oil or cooking oil)
(5-30 g, as appropriate) was dissolved in petroleum ether 
(b.p. 40-60° ) and a solution of sodium borohydride (500 mg) in 
ethanol (10 ml) was added with stirring. After stirring for I5 
min the turbid liquid was treated with 2 M hydrochloric acid.
The resultant lower acid layer was collected and the upper organic 
phase was extracted twice with 2 M HGl. The combined acid layers 
were basified (NaHCO^ solution) and extracted into chloroform.
The dried chloroform extract was evaporated, the residue was 
dissolved in ethanol, and the volume was adjusted to 1.00 ml in a 
standard flask.
Samples (2-20 pi) of this ethanol solution were spotted onto 
a 20 X 20 cm plate coated with silica gel (250 pm) in the usual way.
135
.The spot rims were then scored and the chromatogram was developed 
over 10 cm with benzene-methanol (6:1). The plate was dried (air 
blast for 5 min), then irradiated with long-wavelength UV light 
for 15-20 min to effect oxidation of dihydrosanguinarine to 
sanguinarine. The latter appeared as an orange spot at O.78. 
This was removed from the plate with the micro suction apparatus, 
dissolved in ethanol containing one drop cone,. HCl and the 
solution made up to 5 «00 ml in a volumetric f^ask. The absorbance 
of this solution at 330 nm was measured and the concentration of 
sanguinarine computed from a calibration curve of concentration 
of pure sanguinarine chloride vs. extinction at 330 nm. Usually 
ten samples of the test solution were processed on one plate and 
the average concentration was calculated.
CHAPTER 3
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THE ROLE OF SANGUINARINE IN THE PRODUCTION OF
CANCER OF THE STOMACH AND OESOPHAGUS
Introduction
In a series of experiments designed to investigate the 
transmission of orally administered sanguinarine to milk and
114
urine, Hakim et al noted the presence of several compounds 
which were absent from the milk and urine of control subjects. 
One of these compounds was investigated and identified, purely 
on the basis of its ultra-violet spectrum and electrophoretic 
behaviour, as being benz(c)acridine (161 )
(151)
Further experiments showed that the metabolite was present in 
greatest quantities in the livers of animals fed on sanguinarine 
rich diets. Perfusion of an isolated rat’s liver with blood to 
which sanguinarine in saline had been added led to the release 
of the ’metabolic’ product in four hours. Hakim states that 
this product must be derived from sanguinarine since it was 
always absent in control studies.
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Hav/ing'identified' the metabolite as benz(c)acridine Hakim 
and his co-workers realised the carcinogenic implications of a 
compound in this class of polynuclear heterocyclic hydrocarbons
152which had already been synthesised by Lacassagne, Some members 
of this group, for example, 5,10-dimethylbenz(c)acridine (152)





Experiments were undertaken by Hakim to induce cancers in 
experimental animals both by feeding of Argemone oil and 
sanguinarine, direct i.u. injection of oils, and by implanting 
benz(c)acridine in wax pellets into the bladders of rats. 
Increases in the numbers of cancers over the controls were 
claimed.
15A
Hakim implicates benz(c)acridine as the cause of 
oesophageal and of stomach cancers on the basis that 
sanguinarine is actively secreted into these organs after 
systemic absorption, although no evidence is offered for the
1 3 8
similar secretion or concentration of benz(c)acridine in either 
organ.
108,154
Finally, Hakim presents demographic data to correlate the 
incidence of gastric cancers with climate, geographical location 
and social class or race. He shows, for instance, a variation 
in the incidence of oesophageal cancer with edible oil usage of
155different Indian social classes (linking oesophageal cancer 
with the adulteration of edible oils described above). Quoting
156the study of Kmet and Mahboubi on the distribution of oeso­
phageal cancers in the coastal areas of the Caspian Sea in 
Iran, Hakim notes that the incidence of this cancer is rela­
tively high in the drier regions as compared with the wet,
157,158tropical regions, and points out that this distribution is 
similar to that of the Iranian papaveraceae.
A considerable amount of evidence of this nature is pro­
posed but it must be regarded with suspician because of the 
variety of sources and the lack of any scientific control over 
the data gathering: sudden increases in the incidence of a 
particular disease may simply indicate the upgrading of local 
health care or a renewed medical interest in specific diseases. 
Similarly, differences of disease incidence between social 
classes or races may indicate differences in the standard of 
health care available or in the attitude of a particular race 
or class to health care.
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The search for environmental causes for diseases must be 
investigated in a controlled, scientific manner over many years, 
and not on the basis of fortuitous coincidences as appears to be 
the case with benz(c)acridine.
In order for benz(c)acridine to be produced from sanguin- 
arine in-vivo the following transformations must take place, 
although not necessarily in the order shown below;
1. N-demethylation
2.a) cleavage of the methylenedioxy groups followed by
2,b) dehydroxylation
3, rearrangement of the benzo(c)phenanthridine skeleton 
to that of benz(c)acridine.
159
Certainly, the reactions 1, 2,a) and 2,b) are known in-vivo 
transformations and the N—déméthylation product of sanguinarine, 
norsanguinarine (10), has been observed in extractsof monkey 
urine.
( 1 0 )
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Products derived from reactions 2,a) and 2,b) were not identi­
fied, although they should have been present if this type of 
detoxification system is operating.
The rearrangement of the benzo(c)phenanthridine is a
profound metabolic transformation of a type which has not been
160-162reported in-vivo, although there are some in-vitro analogues. 
The transformation would be most simply achieved by re-orien­
tation of the benzo(c)phenanthridine A-ring as shown below;
It must be asked why this type of reaction should occur and it 
is difficult to put forward any reason unless it is that the 
shape of the sanguinarine molecule closely mimics some other 
molecule of physiological origin which undergoes this reaction, 
Under normal circumstances metabolism takes place in the endo­
plasmic reticulum of the liver and is essentially a hydroxyl­
ation process; introduction of a hydroxy group is usually 





Since sanguinarine readily forms its 6-hydroxydihydro- derivative, 
this could form the glucuronide and the sanguinarine excreted 
essentially unchanged. Alternatively, the 6-hydroxy- derivative 
could be removed by conjugation with a thiol residue of a 
protein.
Since it is possible for the body to deal with sanguinarine 
simply it is unlikely to be involved in major structural 
changes. Another possibility exists, which is that sanguinarine 
triggers the release of other compounds or stimulates their 
production by interfering with biochemical processes. An 
example is provided by the production of neurohormones in the 
eye after stimulation of the hypothalamus by sanguinarine, 
mentioned above (p,92).
A final possibility is, of course, that benz(c)acridine is 
not present and that its earlier identification by Hakim et al.
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was a case of mistaken identity. In this context it should be 
remembered that the only criteria of identity were the ultra— 
-violet spectrum, the electrophoretic behaviour, and the com­
parison of these properties with an authentic sample. Although 
this is sufficient in less critical applications, it is simply 
not enough evidence on which to base a theory with such far- 
-reaching implications.
It is quite possible that in experiments in which the 
ingested substance was Argemone oil or foliage, the 'metabolites' 
could simply be trace alkaloids of Argemone mexicana. This 
could also be the case when sanguinarine chloride was used 
since the source of the material used in Hakim's work was
151invariably extracts of A, mexicana.
In studies carried out by the author, benz(c)acridine has 
not been found on any occasion in any samples of blood or urine 
which were obtained during the course of feeding experiments 
with cats, rabbits or monkeys using either A,mexicana seed oil 
or sanguinarine (samples provided by Dr Hakim), Benz(c)acridine 
was not found in the organs or viscera of animals sacrificed 
after feeding experiments. The same result was obtained both 
for chronic and for acute studies.
Similarly, benz(c)acridine was not found in samples of 
sheep livers obtained by Dr Hakim from Iceland, an area where
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the incidence of gastric cancers is high and where the available 
grazing land had a high density of papaveraceous plants.
It is considered by this author that the ’metabolites* 
detected by Hakim et al are not products of metabolism but 
extraneous alkaloidal material which has been concentrated by 
the liver. This is not improbable, since no attempts at purifi-
151cation of the sanguinarine chloride samples were made. In all 
cases where extracted alkaloid was used a mixture mainly of 
sanguinarine chloride and dihydrosanguinarine hydrochloride was 
obtained by treatment of a dry ethereal solution of seed oil 
with dry hydrogen chloride gas. The whole of the precipitated 
material was oxidised by aqueous ferric chloride and the 
quarternary chloride recrystallised from 2M hydrochloric acid.
It has been found that sanguinarine chloride obtained by this 
method contains several impurities among them berberine, 
protopine and chelerythrine. The identification data quoted by 
Hakim et al, which is an ultra-violet spectrum and some electro- 
-phoresis data could equally be applied to berberine, which 
also fluoresces green under uv light.
Initial work concentrated on developing a method for the 
rapid determination of benz(c)acridine. It was soon discovered 
that benz(c)acridine was very amenable to glc analysis, rapidly 
eluting from an SE30 (silicone) column at relatively low 
(215°C) temperature. It was also found that benz(c)acridine
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could be separated from a crude mixture of monkey urine bases 
obtained from urine concentrates by direct chromatography of a 




monkey u r ine  bases benz(c)acridine
■benz(c)acridine
13min
Since the method was so simple for benz(c)acridine it was hoped 
that it could be extended to include sanguinarine. It was 
realised that the ionic nature of the aromatic compound would 
preclude gas chromatography and that the only possibility was 
to form a derivative more amenable to this type of analysis. 
Since attack at the 5-position to give 5,5-dihydro derivatives
1 4 5







p -ph eny I hyd ruzine
(165)
The pseudobase (155 R=0H) was found to be thermally unstable, 
as was the pseudocyanide (265 R=CN). Silyl derivatives of the 
pseudobase could not be prepared. The 6-methyl- and 6— &- 
phenylhydrazinyl- derivatives were made but did not produce 
suitable chromatograms. Initial results with the 6-acetonyl- 
derivative (165 Rs^HgCOCHg) were encouraging but it was soon 
realised that the chromatograms obtained were due to thermal 
decomposition products. 5,6-dihydrosanguinarine (165 R=H) was 
found to elute, but as a very broad peak at elevated tempera­
tures and extended times, thus making it unsuitable for 
analysis.
The search for a glc method for sanguinarine was abandoned 
since the tic approach was by this time giving extremely good 
results. It was, however, retained for benz(c)acridine 
screening.
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EXAMINATION OF PHYSIOLOGICAL SAMPLES
Monkey urine collected during several feeding experiments 
using A.mexicana oil was presented for examination as dried 
residues. After rehydration with water the samples were sub­
jected to acid hydrolysis to break down any protein complexes; 
neutralisation was followed by treatment with sodium boro- 
hydride which, after fifteen minutes, was decomposed by the 
addition of dilute acid. The solutions were worked-up for 
bases in the usual way. The crude residue of monkey urine 
bases was made up to standard volume with chloroform and sub­
jected to analysis for sanguinarine by tic analysis (see 
Chapter 2) and for benz(c)acridine by glc analysis.
Results from Monkey 121 showed that sanguinarine is 
excreted in the urine of animals fed on sanguinarine rich diets, 
although not in the quantities that the feeding rate would lead 
one to expect. This attenuation of sanguinarine concentration 
can be ascribed to several mechanisms:
i) non-absorption from the gut: majority of 
sanguinarine excreted in faeces 
ii) removal of sanguinarine as protein complex in
serum and thus reduced availability for excretion 
iii) metabolism 
iv) concentration in an organ or organs.
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TABLE 20
EXAMINATION OF TISSUE SAMPLES 
MONKEY NO, 122










a = green fluorescent tic spots
MONKEY NO 121
organ sanguinarine benzacridine others identity
I iver X — —
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An investigation was undertaken into the possibility of 
concentration in organs (iv) and the organs of a monkey (Monkey 
No. 122) which had been fed on a sanguinarine rich diet for 
thirty days prior to death were examined. The organs, which 
were presented in dehydrated form, were ground in a laboratory 
mill prior to rehydration and acid hydrolysis. The standard 
analytical procedure was followed. Although sanguinarine was 
found in the lungs, liver and kidney, it was not found in 
sufficient quantities to explain the attenuation of sanguin­
arine. Surprisingly, none was found in the blood. The testes, 
heart, spleen and some muscle tissue was also examined but no 
interesting compounds were found.
Identical spots on the tic chromatograms of the kidney 
extracts of Monkey No. 122 and in the liver and urine of Monkey 
No. 121 were found to exhibit green fluorescence under ultra- 
-violet light and attempts were made to isolate these by 
preparative thin layer chromatography. Work-up of the relevant 
area of the preparative plates produced very small amounts of 
material, which on subsequent tic exhibited total loss of the 
original component; mixtures were obtained in which Argemone 
components were obvious. Results are summarised in Table 20,
The major factor in the attenuation of sanguinarine would 
be expected to be nonabsorption (i) since the sanguinarine was 
presented to the system as a solution in oil; its bioavail­
ability would be relatively low and would be very dependent on
U 9
the residence time in the stomach as it is only there that the 
pH is sufficiently low to extract the alkaloid from the oil 
phase. Collection and analysis of urine and faeces would have 
allowed the degree of absorption to be assessed but samples 
were not made available.
Serum protein binding is accepted as a major contributor 
to the attenuation of pharmacologically active substances after 
absorption into the blood. The extent of serum protein binding 
was impossible to assess: since the degree of absorption was 
not known it was not possible to assess the difference between 
the amount absorbed and the amount excreted.
Problems were encountered in analysing the urine extracts 
for metabolites since the feeding regimes had been carried out 
using either the expressed seed oil of Argemone mexicana or a 
crude mixture of alkaloid chlorides and hydrochlorides precipi­
tated from an ether solution of the seed oil. Although 
sanguinarine was the major component in both cases the presence 
of extraneous alkaloidal material, also capable of systemic 
absorption and subsequent excretion, complicated matters 
considerably, in that it was difficult to establish the source 
of any material other than sanguinarine extracted from the 
urine. The appearance of a tic spot could simply signify the 
preferential excretion of a minor component of the original 
feedstuff rather than the metabolism of the sanguinarine. The
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absence of material from control animals also hampered the 
interpretation.
Examination of liver tissue
Liver samples were provided in dehydrated form and were 
ground in a laboratory mill prior to rehydration and acid 
hydrolysis. The standard analytical procedure was followed and 
samples were subjected to tic analysis for sanguinarine, and 
glc analysis for benz(c)acridins. The results are shown in 
Table 21, It can be seen that sanguinarine was tentatively 
identified in three out of the forty-one samples. Benz(c)- 
acridine was not found in any of the samples, but an unident­
ified compound was detected in two cases. Small sample size 
precluded any confirmatory studies.
It may be significant that sanguinarine was detected in 
three of the samples since Iceland is a major supplier of liver 
and liver products to Europe, However, key information 
concerning the origin and history of the samples was held by 
Dr Hakim and was not made available before his unfortunate 
death. The Sola Hakim Centre for Medical Research where 
records were presumably kept has also ceased to function.
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RESULTS OF INVESTIGATIONS OF LIVER SAMPLES; 
ICELANDIC SHEEP
SAMPLE ' WEIGHT(GM) ' RESIDUE WT.(MG) SANGUINARINE ' BENZACRIDINE
1 16.5 7 absent absent
2 14.8 1 X 11
3 14.6 2 absent II
4 14.7 2 X II
5 15.8 6 absent II
6 14.2 1 X II
7 14.3 8 b I
8 15.2 4 absent II
9 13.2 5 tt II
10 15.5 5 tt II
11 14.1 4 II II
12 13.8 4 II II
13 14.7 6 II II
14 14.9 7 II II
15 14.5 5 M II
16 16.1 3 II II
17 14.6 5 b II
18 14.5 12 absent II
19 14.0 6 II II
20 15.1 3 II II
21 12.5 7 II II
22 11.6 3 II II
23 15.7 6 II II
24 12.2 8 II II
25 11.4 4 II It
26 13.5 3 II II
27 11.2 2 II II
28 11.0 5 II II
29 11.9 8 II II
30 12.6 4 II H
31 12.6 4 II II
32 9.7 5 II II
33 9.2 3 II II
34 8.2 1 II II
35 9.0 4 II II
36 8.0 2 II II
37 9.0 1 II II
38 8.2 3  ̂ II II
39 8.5 3 II II
40 9.3 3 II II
41 8.7 5 II II
b = unidentified gold spot R^ 0.55
EXPERIMENTAL
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GAS-LIQUID CHROMATOGRAPHY OF 
BENZ(C)ACRIDINE
Using material prepared as above and recrystallised three 







2 |4l aliquots were applied to a glc apparatus and the peak 
areas calculated. 10 replicates of each concentration were 
chromatographed. Mean peak area was plotted against concen­
tration and a straight line fitted. The calibration curve 
obtained is shown in Figure 12.
Benz(c)acridine was added to solutions of extracts of 
dried urine and liver prior to chromatography. The expected 
amount of benz(c)acridine was detected in the chromatogram.
Benz(c)acridine wasadded to portions of reconstituted
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dried urine prior to extraction. For the purposes of this 
study, reconstituted urine was extracted both by
a) a standard extraction procedure for basic material
b) the sodium borohydride treatment described above.
In both cases the extraction rate was nearly 98%. No 
statistically significant difference was found between the 
two procedures. Results are summarised in Table 2%.
15A
TABLE 12









E x t r a c t io n  of benz(c |ac r id ine : reco ve ry  of
m ate ria l actied to re c o n s t i tu te d  dried monkey urine
i s tan da rd  base w o rk -u p
ii sodium borohydride p ro ce d u re
amount ac/ded^ 
to TOgm dried 
monkey urine
i ) standard ii ) borohydride
mg/gm Vo mg/gm %
I'O mg -984 984 •980 98 0
_ O'5 " •494 987 •495 990
. 0-3 •296 98*7 •295 98-5
0-1 " •099 994 •098 964
0̂  05 w '0495 98-9 •0491 98-2
0 '03 " •0291 971 •0292 974
O'OI « *00 96 96-3 •0097 95-9
a ? sol u t ion  in CHCI3
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Preparation of benz(c)acridine (161)
1-naphthol (12.0gm,0.083M) and ortho-toluidine hydro­
chloride (IIgm,0,076M) were intimately ground together and 
then heated at 230°C for 4.0 hours. After cooling the mass 
was treated with warm 20% potassium hydroxide solution (200ml) 
and toluene (200ml) and allowed to stand for twenty four hours. 
The layers were separated and the aqueous layer extracted 
with toluene (3 x 200ml). The combined toluene extracts 
were washed with water (2 x 200ml), dried over magnesium 
sulphate and the toluene removed under reduced pressure to 
leave an oil (8.0 gm). Vacuum distillation at 0,3mm.Hg,
160°C produced an oil, (6.25gm).
The product of the above reaction (6.0gms) and lead
oxide (60gm,0.27M) were heated at 240°C for four hours.
After cooling the mass was extracted with diethyl ether
(200ml). Removal of diethyl ether under reduced pressure
left a brown gum (S.Ogm) which was treated with hot 2M
hydrochloric acid and stirred for 0,5 hours after which time
the hot solution was decanted. On cooling a yellow
crystalline precipitate was formed. Treatment with 2M
sodium hydroxide solution to alkaline pH was followed by
extraction with chloroform (3 x 100ml). The combined organic
extracts were washed with water (2 x 100ml) and dried over
magnesium sulphate. Removal of chloroform under reduced
pressure produced a solid which was recrystallised from
ethanol to give benz(c)acridine as yellow crystals (2gms,




INVESTIGATIONS INTO THE SYNTHESIS OF 
RADIOLABELLED SANGUINARINE DERIVATIVES
In order to investigate the proposed in-vivo rearrange­
ment of sanguinarine to benz(c)acridine it was decided to
14synthesise derivatives of sanguinarine containing a C label 
in the benzo(c)phenanthridine skeleton. The label would have 
two functions:
i) it would confirm that any metabolite found was 
derived from sanguinarine
ii) it would throw some light on the mechanism of the 
proposed rearrangement reaction since the position 
of the label in the metabolite could be determined 
by degradation.
14Since the C label was to act as a metabolic tracer
it was important that it should not be in an easily metabolised,
reactive position. This precluded the substitution of the
sanguinarine 6-position, the N-methyl group or either of the
14methylenedioxy carbon atoms. Similarly, the C label might 
have been lost had it been placed in either of the peripheral 
benzene rings. It was decided that the most suitable position 
for both avoidance of label-loss and simplicity of synthesis 
would be either the C-11 or C-12 positions.
Two synthetic approaches were considered. The first 
involved the synthesis of the vinyl compound (155) derived 
from a protopine type of compound. Removal of the terminal
158
14,methylene group and its replacement by a C labelled group would 
be followed by photocyclisation after the method of Onda,^
(166)
The second method involved ring expansion of the indenoisoquinoline 
(157) with radiolabelled diazomethane.
(167)
The initial work was intended to establish the synthetic 
routes using non-radiolabelled reagents. Part I describes the 
attempts to modify the vinyl group of (165), Part II des­
cribes the synthesis and attempts at ring expansion of (157).
PART I
Due to its availability, cryptopine (158) was used as a 
model compound in this study.
The conversion of cryptopine to the vinyl compound, anhydro- 






Cyclisation of (168) with POCl^ is followed by Hofmann 
degradation with methanolic potassium hydroxide to give the 
vinyl compound, anhydrocryptopine. Irradiation with ultra­
violet light followed by catalytic dehydrogenation would give 
the fully aromatic benzo(c)phenanthridine.
It was hoped to cleave the vinyl group oxidatively to the 
aldehyde, then to reform the vinyl group by reacting with 
radiolabelled methyl magnesium bromide followed by dehydration 
of the alcohol thus formed. Alternatively an organometalic 
reaction on the acid was to be used.
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(171) ( 1 7 2 )





169iv) KMnO^/quarternary ammonium halide 
No success was achieved although several compounds were 
detected and assigned structures on the basis of their mass 
spectra.
Initial attempts to cleave the vinyl group with potassium 
permanganate led to the quantitative recovery of the
1,2-dihydro-1,2 -0 X 0 -  compound. Reaction of this compound with 
ozone in methylene chloride solution gave no detectable prod­
ucts, and starting material was recovered quantitatively.
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In separate experiments the oxo- compound ( 172) was 
treated with a permanganate/periodate mixture and with an 
osmium tetroxide/periodate mixture; in both cases the main 
component of the recovered material was the starting compound 
although in both cases an unidentified compound with a molecular 
weight (mI*) of 393 was detected in low concentration in the 
mass spectrometer.
Reaction of the oxo- compound with potassium permanganate 
and trimethylcetyl ammonium bromide in benzene ('purple benzene*) 
failed to produce the aldehyde derivative although small quan­
tities of two oxidation products were detected. These have been 
tentatively assigned the structures (173) and (174) although 
there was insufficient material for complete characterisation.
(173) (174)
Reactions were carried out on anhydrocryptopine in the same way 
both permanganate/periodate and osmium tetroxide/periodate 
oxidations proceeded exothermically and produced tars which 
proved impossible to separate. It was clear, however, that the 
desired aldehyde had not been formed. Ozonolysis again proved 
unsuccessful. Reaction with 'purple benzene' proceeded exo­




Reduction of anhydrocryptopine with sodium borohydride 
in ethanol gave the I,2,3,4-tetrahydroisoquinoline (171) 
which on ozonolysis gave the 1,2-dihydro-1 -oxo-isoquinoline 
in both dichloromethane and in formic acid. Oxidation with 
both permanganate/periodate and with osmium tetroxide/periodate 
led to the formation of I,2,3,4-tetrahydro-I,2-oxo- and
1,2-dihydro-I,2-oxo-isoquinoIines in low yield plus unreacted 
starting material.
Treatment of the tetrahydroisoquinoline with iodine and 
sodium acetate produced the fully aromatic isoquinolinium 
iodide.
It is difficult to explain the apparent lack of reactivity 
of the aryl vinyl group, since this function in other, similar, 
environments has been shown to cleave. Obviously, in the case 
of the 1,2-dihydroisoquinoline, and the 1,2,3,4-tetrahydro- 
isoquinoline the oxidation to the 1,2-oxo- compound is the 
lower energy reaction path, but this part of the compound, 
once formed, appears to deactivate the vinyl group although it
1 6 3
is not in direct conjugation with it.
This deactivation could not be overcome by manipulation 
of conditions or reactants since the energy required to cleave 




The indeno(1,2-c)isoquinoline skeleton is numbered in the 







The indeno(1,2-c)isoquinoline system has received little
170
attention until recently, Chatterjea and Mukerjee synthesised 
(176) by treatment of (177)> obtained by polyphosphoric acid 





171'The basic skeleton (1 /̂ ) has been synthesised by Wawzonek by 
reductive decarboxylation of the carbarayl derivative (178) 




More recently, in an extensive re-examination of Perkin's
167work on cryptopine (16%), Dyke and Brown showed that the product 
of the reaction of anhydrocryptopine (180) with concentrated 




Work by Dyke, Palfreyman et al. showed that sodium borohydride 
reduction of the 4-acyl isoquinoline (182] to the alcohol (18>3) 
followed by treatment with ethanolic hydrochloric acid caused 




( 1 8 4 : )
The mechanism proposed involves a nucleophillic attack 
of the isoquinoline C-3 position by the free para- position 
of the dimethoxybenzyl group, with loss of the benzylic 
hydroxy function. Rearomatisation of the D-ring leads to the 
1lH-indeno(1,2-c)isoquinoline.
In a programme of work designed to produce oxygenated
analogues of the indeno(1,2-c)isoquinoline ring system
74Wiggins attempted to form the 4-benzylisoquinolinium salt (185) 
by acid catalysed condensation of the benzylaminoacetaldehyde- 








Instead of the 4-benzyl compound the 2,3,8,9-tetramethoxyindeno- 
(1,2-c)isoquinoIine (188) was isolated.
The mechanism of the reaction is thought to involve nucleophillic 
attack of the veratraldehyde carbonyl carbon atom by the C-4 
position of a proposed 1,2-dihydroisoquinoline intermediate 
formed by ring closure of the dimethylaceta1 (186). The inter­
mediate thus formed would ring-close by nucleophillic attack 
of the isoquinoline C-3 position by the free position para- 
to the 3-methoxy group of the dimethoxybenzyl moiety to give (189). 
Dehydration and dehydrogenation would give the product isolated. 
Variation of reaction conditions optimised the yield, and it 
was found that the best yields were obtained by heating the 
reactants at reflux temperature for six hours in 9M hydrochloric acid,
167





by treating (188) with sodium dichromate in acetic acid.
It was hoped at this point to mimic the behaviour of 
fluorenone (191) by ring-expanding the lI-ketoindeno(1,2-c)iso- 
quinoline to the benzo(c)phenanthridine using diazomethane.
0
191
The reaction had been shown to proceed with fluorenone by
173Schultz, and the infra-red C=0 stretching frequencies of the 
two compounds were close enough (1690cm  ̂for the 11-ketoindeno* 
(1,2-c)isoquinoline and 1709cm  ̂for fluorenone) to expect a 
similar reaction to proceed with the indeno compound.
Unfortunately, Wiggins was unable to produce the ring expanded 
product using either etherial solutions of diazomethane or 
diazomethane generated in-si tu. The same lack of reactivity 
was demonstrated by the methosulphate.
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Further investigations by Wiggins showed a complete lack of 
carbonyl reactivity by the ll-ketoindeno(1,2-c)isoquinoline 
and by the ll-ketoindeno(l,2-c)isoquinolinium methosulphate 
although similar ketone reactions had been achieved with 
fluorenone by Schultz.
This synthetic approach was particularly interesting to 
this author since ring-expansion of the ll-ketoindeno(1,2-c)iso- 
quinoline with diazo-^^C-methane would lead to a benzo(c)phenan- 
thridine labelled at either C-11 or C-12. Choice of suitable 
precursors and suitable post ring-closure reactions could lead 
to radiolabelled sanguinarine.
Consequently, and in spite of the unsuccessful attempts 
described above, it was decided to try this synthetic approach 
again. It was felt that the similarity of the 11-ketoindeno- 
compound to fluorenone was such that variation of the conditions 
of reaction must lead to eventual success.
The reaction of diazomethane with ketones has been reviewed 
1%by Gutsche and a mechanism has been proposed. Initial nucleo­
phillic addition of methylene to the carbonyl group forms the 
zwitterion (192) which decomposes to form either the epoxide (193) 
or the 1,2- rearrangement products (194) and (195) with loss of 
molecular nitrogen. All three have been reported but usually
1 6 9
one product is preferred.
' 1






R;j‘fc— C H 2 ~ R  (195)
Using the benzylaminoacetaldehydedimethylacetals (196) aiid 
(197 in condensation reactions with veratraldehyde this author 
prepared the ll-ketoindeno( 1,2-c)isoquinolines (198) and (199) 
by the action of sodium dichromate on the respective 
llH-indeno(l,2-c)isoquinolines. Ring-expansion of the 11-keto-
175compounds with etherial solutions of diazomethane failed as before, 
In-situ production of diazomethane using the powerful diazomethane
176generator p-tolylsulphonylmethylnitrosamide (200) also failed 
to produce the desired ring-expansion product.
It was unfortunately found to be necessary to abandon work
170












Although both routes studied above were interesting and
deserve further study it is considered that the best and simplest
method of inserting a label at C-11 would be to use the method of





Some development work was done on this synthetic route, 
mainly aimed at improving the yields of the early stages. To 
this end, greater homogenisation of methylene iodide led to 
increased yields and shorter reaction times for the production 
of the methylenedioxy acid (201),
CH.WNaOH ^
V - 0 C02Na 
201 )
Similarly the Eosenmund catalytic reduction of the acid 
chloride to the aldehyde (202) was replaced by reduction of the 
acid chloride by an aluminium hydride reduction which led to a 










Preparation of isocryptopine chloride (169)
To cryptopine (168) (13.9gm,0.036M) was added phosphorus 
oxychloride (28ml). The buff coloured slurry thus formed 
was heated at reflux temperature for 0.75 hours, after which 
time it was poured into cold water, with stirring and cool­
ing. The solid, which was collected by filtration, was re­
crystallised from 2M hydrochloric acid to give isocryptopine 
chloride (11.5gm,857.)) 0  1610cmmax
Preparation of anhydrocryptopine (170)
Isocryptopine chloride (1.70gm,4.5mM) was heated with 
a 257# solution of potassium hydroxide in methanol at 100°C 
for 0.75 hours. The reaction mixture was cooled and the 
solids collected by filtration. After washing with water 
the solid material was recrystallised from methanol to give 
anhydrocryptopine (1.0gm,60%) MPt 104°-108°C
\) 1610cm  ̂ 1605cmmax
Attempted osmolysis of anhydrocryptopine
Anhydrocryptopine (480mg,1.3mM) was dissolved in 
(LiAlH^ distilled) dioxane (15ml) and water (4ml). Addition 
of osmium tetroxide (5mg) produced an immediate browning. 
Addition of sodium periodate (500mg) caused an exothermic 
reaction. After 2.0 hours the mixture was diluted with 
water (50ml) and extracted with chloroform (4 x 50ml);
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The combined organic extracts were washed with water (2 x 50ml) 
and dried over magnesium sulphate. Removal of chloroform under 
reduced pressure afforded a black tar which proved unseparable.
Attempted permanganate/periodate oxidation of anhydrocryptopine 
Anhydrocryptopine (500mg,1.35raM) was dissolved in the 
minimum amount of acetone and 20ml of 0.05M potassium carbonate 
solution added as a buffer. Addition of 0.2M sodium periodate 
solution (10ml) followed by 0.0005M potassium permanganate 
solution caused immediate reaction with generation of heat. 
After 2.0 hours the reaction mixture was treated with sodium 
thiosulphate solution and extracted with chloroform (3 x 50ml). 
After washing with water (2 x 50ml) and drying over magnesium 
sulphate the chloroform was removed to yield an intractable tar.
Attempted ozonolysis of anhydrocryptopine
Anhydrocryptopine (110mg,0.3mM) was dissolved in hot 
methanol (25ml) and rapidly cooled to produce a fine suspen­
sion. A mixture of ozone and oxygen from an ozone generator 
was bubbled through the suspension for three hours, when zinc 
dust (50mg) and water (25ml) were added to destroy the ozonide. 
The mixture was allowed to stand for twelve hours after which 
time the reaction mixture was worked-up. Starting material was 
recovered quantitatively.
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Preparation of dihydroanhydrocryptopine (171)
Anhydrocryptopine (2.0gm,5,4mM) was stirred in 507.
aqueous ethanol (100ml) and sodium borohydride (160mg) added
in portions. After overnight stirring the reaction mixture
was concentrated under reduced pressure. Water (40ml) was
added and the suspension extracted with chloroform (3 x 50ml).
The combined organic extracts were washed with water (2 x 50ml),
dried over magnesium sulphate, and the chloroform removed under
reduced pressure to give the tetrahydro- compound (171 ) as a
rapidly deteriorating brown semisolid ( 1.80gm,907.).
0 =1610cm’ ,̂ 353.max
The product was isolated as the perchlorate salt and 
recrystallised from aqueous ethanol.
Reoxidation of dihydroanhydrocryptopine
Dihydroanhydrocryptopine (500mg,1.3mM) was treated with
57. aqueous potassium carbonate solution (30ml) and the sol­
ution extracted with diethyl ether (3 x 50ml). The combined 
organic extracts were washed with water (2 x 50ml), dried over 
magnesium sulphate and the diethyl ether removed under reduced 
pressure. The residue was treated with iodine (lgm,7.8mM) in 
a solution of ethanol (100ml) and sodium acetate (5gm).
After stirring for 1.0 hours the reaction was treated with a 
solution of sodium thiosulphate (2.0gm) in water (100ml) and 
stirred for a further 0.5 hours. Work-up produced a brown 
glass which was triturated with petroleum ether (40^-60°) to 
give a pale brown solid (380mg). Mass spectrometry showed this
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to be a mixture of the fully aromatic isoquinolinium iodide 
and ketoanhydrocryptopine. The solid was taken up in 2M 
hydrochloric acid and filtered. Addition of sodium perchlorate 
gave the fully aromatic isoquinolinium perchlorate as a yel­
low solid. MPt 280°C-282°C. M^350.
Osmolysis of dihydroanhydrocryptopine
Dihydroanhydrocryptopine (500mg,1.3mM) was dissolved in 
dioxane (15ml) and water (4ml). Osmium tetroxide (5mg) 
was added, followed by the stepwise addition of solid sodium 
periodate (500mg) over 0.5 hours, after which the reaction was 
stirred for a further two hours. Water (40ml) was added and 
the solution worked-up. The semisolid isolated (450mg) was 
a mixture of starting material (M^353), and the 1-oxo- 
derivatives of anhydrocryptopine (M^365) and dihydroanhydro- 
cryptopine (M 367) by comparative tic.
Ozonolysis of dihydroanhydrocryptopine
Dihydroanhydrocryptopine (Igm,2.7mM) was dissolved in 
60% formic acid (50ml) and a mixture of ozone and oxygen 
bubbled through the solution for 3.0 hours. The solution was 
neutralised with 30% sodium hydroxide solution and treated with 
zinc dust. Filtration was followed by extraction of the filtrate 
with dichloromethane (3 x 50ml). The combined organic layers 
were washed with water (2 x 50ml) and dried. Removal of the 
dichloromethane afforded ketoanhydrocryptopine (0.25gm)
with 30% sodium hydroxide solution was followed by extraction
0 1662cm ,M 365. Basification of the aqueous filtrate abovemax
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with diethyl ether (3 x 50ml) which after drying and evapor­
ation under reduced pressure gave the starting material (0.60gm).
Periodate/permanganate oxidation of dihydroanhydrocryptopine 
Dihydroanhydrocryptopine (l.Ogm,2.7mM) was dissolved in 
dioxane (25ml) and treated with a solution of sodium periodate 
(0.75gm) and potassium permanganate (25mg) in water (5ml).
After stirring for 2,0 hours the solution was diluted with water 
and extracted with chloroform (3 x 50ml) which on evaporation 
gave an oil (0.6gm) which proved to be a mixture of starting 
material and ketoanhydrocryptopine.
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Preparation of ketoanhydrocryptopine (172)
Anhydrocryptopine (3,0gm,8, linM) and actiye manganese 
dioxide (2,0gm) were stirred in dry benzene oyernight. After 
evaporation of benzene the solid was extracted with hot glacial 
acetic acid which was poured into water and the aqueous solu­
tion extracted with diethyl ether (4 x 100ml). The combined 
organic extracts were washed with 5% sodium bicarbonate solu­
tion (2 X 100ml), water (2 x 100ml) and dried over magnesium 
sulphate. Evaporation of solvent under reduced pressure gave 
the required isocarbostyril (2.Igm,72%) >^^^^1662cm
Ozonolysis of ketoanhydrocryptopine
Ketoanhydrocryptopine (0.5gm,1.3mM) was dissolved in 
dichloromethane (50ml) and a mixture of ozone and oxygen 
bubbled through for three hours. The solution was then shaken 
with zinc powder (200mg) in glacial acetic acid (30ml) for
1.0 hours. Zinc was removed by filtration and water (50ml) 
added. The layers were separated and the organic phase re­
tained. The aqueous phase was extracted with dichloromethane 
(3 X 50ml) and the combined organic layers washed with 
aliquots of water until the washings were neutral. Treatment 
of the organic phase in the normal way produced the starting
iterial (0.45gm) 0 1662cm
Reaction of ketoanhydrocryptopine with potassium permanganate 
solublised in benzene (*Purple benzene*)
r .) Potassium permanganate (Igm) in water (10ml) was stirred 
rapidly for ten minutes. The solution was cooled and benzene (10ml)
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and cetyltrimethylammonium bromide (0.Igm) added, the benzene 
layer immediately took on a purple colouration.
Ketoanhydrocryptopine (0.25g,0.7mM) in benzene (10ml) was 
added and the two phase mixture stirred for 2.0 hours, 
after which time saturated sodium thiosulphate solution was 
added to discharge the colour. After acidification, the 
layers were separated and the aqueous layer extracted with 
benzene (2 x 20ml) and the combined organic extracts washed 
with water (2 x 20ml) and dried over sodium sulphate. Re­
moval of benzene under reduced pressure left a solid (50mg), 
which recrystallised from petroleum ether (40-60°C) as yel­
low plates. No definite melting point could be obtained and 
low energy (lleV) mass spectrometry showed the solid to be a 
mixture, m '̂397 (100%), M^395 (90%). 1710cm” .̂
Attempted osmoylysis of ketoanhydrocryptopine
Ketoanhydrocryptopine was reacted with osmium tetroxide 
and sodium periodate in a manner similar to that described above. 
Starting material was recovered quantitatively.
Attempted oxidation of ketoanhydrocryptopine with permanganate/periodate 
Ketoanhydrocryptopine was treated with potassium permanganate 
and sodium periodate in a manner similar to that described above. 
Starting material was recovered quantitatively.
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PART II
Preparation of 2,3,8,9-tetramethoxv-llH-indeno(l,2-c)isoquinoline( ) 
3,4-dimethoxybenzylaminoacetaldehydedimethyIacetal (I7gm,
0.067M) was heated at reflux temperature with 3,4-dimethoxy- 
benzaldehyde (12gm, 0.072M) for 6.0 hours in 9M hydrochloric 
acid (100ml). The reaction mixture was cooled and extracted 
with diethyl ether (2 x 100ml). The aqueous solution was 
basified with dilute ammonia and extracted with chloroform 
(3 X 150ml); the combined extracts were washed with water, 
dried over magnesium sulphate and the solvent evaporated to 
yield an oil. Dissolution of the oil in acetone followed by 
treatment with dry hydrogen chloride produced the hydrochloride 
salt (4.1gms) which was recrystallised from pyridine (3.5gms,
16%). MPt 268-270°C; 0^^^1620cm"1580cm"^
nmr (TFA): 14 proton complex 4.1-4.35ppm (4 x OCH^, C-11 methylene);
4 aromatic protons (singlets) 7.40, 7.50, 7.60, 7.85ppm;
1 proton (multiplet) 9.2ppm. 
m '̂ 338.
Preparation of ll-keto-2,3,8,9-tetramethoxyindeno(1,2-c)- 
isoquinoline (198)
A solution of 2,3,8,9-tetramethoxyindeno(l,2-c)isoquinoline
(l.Ogm,3mM) in glacial acetic acid (150ml) was treated with a
solution of sodium dichromate (l.Ogm) in glacial acetic acid
(100ml). After heating for 3.0 hours at 100°C the glacial
acetic acid was removed under reduced pressure to yield a
solid that was dissolved in water (200ml) and extracted with
chloroform, (3 x 150ml).
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After washing and drying the chloroform was removed to yield a 
red semisolid which was eluted down an alumina column with 
benzene/chloroform (9:1). After removal of benzene/chloroform 
the red residue was recrystallised twice from benzene to give 
a crystalline solid (0.39gm,40%). MPt 182-185°C
0 1690cm 1580cm ^max
nmr(TFA) 12 proton complex 3.0-3.3ppm (4 x OCH^); 3 proton 
complex 7.45-7.55ppm (3 x aromatic H); 1 proton singlet 8.2ppm 
( 1 X aromatic H); 1 proton singlet 9.Ippm (1 x aromatic H)
M+351.
Attempted ring-expansion
a) External generation of diazomethane.
To a solution of ll-keto-2,3,8,9-tetramethoxyindeno (1,2-c)* 
isoquinoline (0.6gm,1.7mM) in methanol (100ml) was added 
an excess of an ethereal solution of diazomethane. After 
standing at room temperature for several hours the solvent 
was removed under reduced pressure.
Starting material was recovered.
b) In-situ generation of diazomethane
11-keto-2,3,8,9-tetrame thoxyindeno(1,2-c)i soquino1ine 
(40mg,0.llmM) was dissolved in distilled chloroform (30ml) 
and methanolic potassium hydroxide solution (20%,20ml) arid 
water (20ml) added. To this was added N-methyl-N-nitroso- 
p-tolylsulphonamide (200)(Igm) and freshly precipitated 
silver oxide (lOOmg). After stirring at 40°C for 4.0 hours 
the mixture was allowed to separate; the chloroform layer
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was collected and the aqueous phase extracted with further 
chloroform (2 x 30ml). The combined chloroform extracts 
were washed with water (2 x 20ml), dried over magnesium 
sulphate and the chloroform removed under reduced pres­
sure to give returned starting material (30mg,75%).
No other material was isolated.
Preparation of 2,3,7,8-tetramethoxyindeno(l,2-c)isoquinoline ( )
2,3-dimethyoxybenzylaminoacetaldehydedimethylacetal 
(10gm,0.039M) and 3,4-dimethoxybenzaldehyde (llgm,0.066M) were 
heated in 9M hydrochloric acid (45ml) for 6.0 hours at 100 C.
The reaction mixture was cooled and extracted with diethyl 
ether (2 x 50ml). The red solution was basified with dilute 
ammonia and extracted with chloroform (3 x 150ml). The com­
bined chloroform extracts were washed with water (2 x 100ml), 
dried oyer magnesium sulphate and evaporated to give an oil 
which was taken up in acetone and treated with dry hydrogen 
chloride. After two hours a bright yellow crystalline product 
was collected, washed with ethanol and recrystallised from 
pyridine (1.3gms,10%) MPt 240-242°C 0 ̂ ^^1620cm“ 1580cm"^
nmr 14 proton complex 3.9-4.2ppm, (4 x OCH^, C-11 methylene);
1 proton singlet 7.1, 2 proton singlet 7.9, 1 proton singlet 8.2,
1 proton singlet 9.2ppm.
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Preparation of ll-keto-2,3,7,8-tetramethoxyindeno(1,2-c)- 
isoquinoline (199)
2,3,7,8-tetrame thoxyindeno(1,2-c)i soquinoline (337mg,ImM) 
was dissolved in glacial acetic acid (150ml) and treated with 
a solution of sodium dichromate (600mg) in glacial acetic 
acid (150ml). After heating at 100°C for 3.0 hours the 
glacial acetic acid was removed under reduced pressure to 
leave a solid that was dissolved in water (100ml) and ex­
tracted with chloroform (3 x 50ml). After washing with water 
(2 X 50ml) and drying with magnesium sulphate the chloroform 
was removed to give a red brown solid (150mg) which was 
eluted down an alumina column with benzene/chloroform (9:1). 
Removal of benzene/chloroform left a red glass which was 
induced to crystallise with methanol (100mg,307.) MPt 210-215°C
1690cm 1580cm ^max '
nmr 12 proton complex 4.1-4.2ppm (4 x OCH^); 1 proton singlet, 
6.8ppm, 1 proton singlet 7.6ppm, 2 proton singlet 7.8ppm,
1 proton singlet 9.3ppm.
Attempted ring-expansion of ll-keto-2,3,7,8-dimethoxyindeno- 
(1,2-c)isoquinoline
In-situ generation of diazomethane by alkaline decompo­
sition of N-methyl-N-nitroso-p-tolylsulphonamide was carried 
out using the conditions described above.
The starting material was recovered.
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